Clarivate has published the latest edition of Journal Citation Reports® on 28th June, 2022, providing information for the category ranking and Impact Factor ratings of the indexed journals in 2021. According to JCR 2021® , Bentham Science journals have performed well, with 21 Bentham Science journals seeing an increase in their impact factor ratings in 2021.

Current Neuropharmacology remains the most impactful title from our catalog, over the last year, and Its Impact Factor has increased to 7.708.

Another highlight is Current Radiopharmaceuticals, which has received its first impact factor rating of 1.960.

Here is the complete list of impact factor journals published by Bentham Science:

Bentham Science is pleased to announce that Matrix, Inc. (USA) has joined our Institutional Membership Program. Through the Institutional Membership the researchers from the organization get the opportunity to publish their research under an Open Access license, with specified fee concessions, in any Bentham journal. Bentham Science endeavors to make open access publishing partnerships with academic and corporate entities worldwide involved in scientific research and development.

Matrix, Inc. is a privately-held company founded in 2008 by Matrix Industrial Group, specializing in innovative materials-based technology for applications in Nanotechnology and Biotechnology. The company aims to enable the development of Micro- and Nanotechnology-based systems for biomedical engineering, health care technology, and environmental protection through innovative interdisciplinary research and educational programs.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide. Bentham Science currently publishes more than 130 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences.

Kettering General Hospital, (NHS, UK) has joined the Bentham Science Institutional Membership Program. The Membership enables the researchers from the institution to publish their articles as Open Access, under license CC-BY 4.0, at discounted rates in any Bentham journal. Bentham Science aims to promote open research through partnerships with institutions and organizations worldwide, involved in research and developments.

Kettering General Hospital, managed by NHS Foundation Trust, UK, provides access to a range of knowledge resources and services to help healthcare staff and students find and use the best evidence to support patient care, to enhance their studies and professional development and to support research.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide. Bentham Science currently publishes more than 130 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences.

Bentham Science has partnered with the Initiative for Open Abstracts (I4OA) to further increase the visibility of content published in its journals. This partnership aims at enhancing the readership, opportunities for citations, and increase the impact of scientific content among the research community worldwide.

The Initiative for Open Abstracts (I4OA) is a collaboration between scholarly publishers, infrastructure organizations, librarians, researchers and other interested parties to advocate and promote the unrestricted availability of the abstracts of the world's scholarly publications, particularly journal articles and book chapters, in trusted repositories where they are open and machine-accessible.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide. Bentham Science currently publishes more than 170 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences.

JISC and Bentham Science Publishers (BSP) have reached a comprehensive 'Read and Publish' agreement. JISC comprises over 160 leading universities, libraries and research centers all over the United Kingdom as its members. The agreement will allow the authors from the institutions to publish their open access research in BSP's Hybrid and Gold Open Access journals with discount on the Article Processing Charges. Participating universities and libraries will get access to the Bentham Science journals and ebooks collections at a highly discounted price, agreed with JISC. The member institutions can contact JISC or Bentham Science for comprehensive details of the agreement.

Joint Information Systems Committee (JISC) is a not-for-profit company that provides IT services and digital resources to support research and academics in the higher education institutions and research entities in the UK. It provides the universities and colleges with shared digital infrastructure and services and champions the importance and potential of digital technologies for UK education and research.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Bentham Science currently publishes more than 120 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing services, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, and EMBASE.

New Emirates Medical Journal, published by Bentham Science Publishers, has been accepted for inclusion in Scopus. Scopus is one of the largest abstract and citation databases of peer-reviewed literature that includes contributions from selected scientific journals, books, and conference proceedings.

New Emirates Medical Journal (NEMJ), formerly known as the Emirates Medical Journal (EMJ), an official journal of the Emirates Medical Association (EMA), UAE, is an Open Access online journal. The journal provides readers with updates on the progress being made in the medical profession in UAE. The NEMJ publishes original research, clinical reports, case studies, short research communications, reviews, book reviews, correspondence, and editorials. Each peer-reviewed article that is published in the New Emirates Medical Journal is universally and freely accessible to readers around the world.

Prof Abdullah Shehab serves as the Editor-in-Chief of the journal. He has 25 years of experience in Internal Medicine, Cardiology and Interventional Cardiology, and Medical Education. Currently, he serves as Chairman of Scientific Committee in Emirates Medical Association, Vice President of Emirates Cardiac Society and Vice President of Gulf Intervention Society. He is a Fellow of the Royal College of Physicians, American College of Physicians, European Society of Cardiology, American College of Cardiology, American Society of Cardiac Intervention, and Fellow of the American Heart Association.

For more information about the journal, please visit: https://benthamscience.com/journals/new-emirates-medical-journal/

For information about the Emirates Medical Association (EMA): https://benthamscience.com/institutional-members.php

Bentham Science is pleased to announce an Institutional Member Partnership with the Chinese institution, Xiangtan Central Hospital. The partnership makes Xiangtan Central Hospital the first institution from China to join hands in this program. Our Institutional Membership program gives the opportunity to the researchers, from the institution, to publish their research under an Open Access license with specified fee concessions. Bentham Science Publishers welcomes all institutional members from Xiangtan Central Hospital to share their research with our global readership. As a scientific publisher, we will continue to make transformative agreements with established institutions in China and around the world with the goal of easing barriers for member researchers to publish their research.

Xiangtan Central Hospital, China, was founded in 1900, and its predecessor was "Huijing Hospital" opened by the American Presbyterian Church. It is the earliest large-scale national tertiary grade A general hospital integrating medical treatment, teaching, scientific research, prevention and health care in Xiangtan City. Meanwhile, it is also the clinical teaching hospital and postgraduate training base of Central South University and University of South China.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Bentham Science currently publishes more than 130 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing services, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, and EMBASE.

Bentham Science has signed partnership with the Ukrainian Society of Specialists for Immunology, Allergology and Immunorehabilitation for its high impact journal, Endocrine, Metabolic & Immune Disorders – Drug Targets (JCR IF: 2.895). This partnership enables members of the society to publish their research in the journal with substantial concessions on Gold Open Access. The members can also avail personal subscription for the journal with discount.

The Ukrainian Society of Specialists in Immunology, Allergology and Immunorehabilitation (UTIAI) is an association of clinicians, scientists and health professionals, which was established to improve the health of people suffering from allergies and diseases of the immune system. With almost 600 members from all regions of Ukraine, UTIAI is the main source of expertise for all aspects of allergies and immune disorders.

UTIAI membership provides an opportunity to participate in annual conferences, workshops, schools and national congresses on clinical immunology and allergology. UTIAI members are involved in developing and updating standards and guidelines for care for patients with allergies and immune system disorders. For more information, please visit: http://utiai.org.ua/statut

Bentham Science Publishers is a major international science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide. Bentham Science journals are indexed in recognized indexing agencies and Information on our journals’ indexation, by various indexing agencies, can be viewed at https://eurekaselect.com

About the Journal:

Endocrine, Metabolic & Immune Disorders - Drug Targets (JCR IF: 2.89)

This journal is devoted to full-length/ mini reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to the effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbiota composition are welcome.

To learn more, please visit the website: http://eurekaselect.com/journal/196

Bentham Science has signed partnership with the Portuguese Society of Metabolic Diseases for its high impact journals, Current Drug Metabolism (JCR IF: 3.731), Endocrine, Metabolic & Immune Disorders – Drug Targets (JCR IF: 2.895) and Drug Metabolism Letters. This partnership enables members of the society to publish their research in these journals with a considerable discount on Gold Open Access. The members also get the opportunity to avail concession in the charges on personal subscription for the journals.

Portuguese Society of Metabolic Disorders (SPDM), founded in 2002, is a scientific society whose main goal is to bring together professionals from different fields under the scope of inborn errors of metabolism (IEM). SPDM aims to promote awareness of IEM, implementing early diagnosis and therapy in order to increase the quality of life and social integration of all patients.

SPDM encourages scientific research, development of diagnosis and therapeutic protocols and organizes regular clinical and laboratory meetings, pre and postgraduate courses, as well as an annual International Symposium. SPDM promotes and supports the training of professionals in the field of IEM, awarding several scholarships and grants. For more information, please visit: https://www.spdm.org.pt/

Bentham Science Publishers is a major international science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide. Bentham Science journals are indexed in recognized indexing agencies and Information on our journals’ indexation, by various indexing agencies, can be viewed at https://eurekaselect.com.

About the Journals:

Current Drug Metabolism (JCR IF: 3.73)

Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism.

To learn more, please visit the website: http://eurekaselect.com/journal/15

Endocrine, Metabolic & Immune Disorders - Drug Targets (JCR IF: 2.89)

This journal is devoted to full-length/ mini reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to the effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbiota composition are welcome.

To learn more, please visit the website: http://www.eurekaselect.com/journal/59

Drug Metabolism Letters

Drug Metabolism Letters publishes letters, original research articles, mini-reviews, thematic issues based on mini-reviews and letters, commentaries, technical notes and drug clinical trial studies on major advances in all areas of drug metabolism and disposition.

In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; bioactivation; recent developments for the identification of drug metabolites, reactive intermediate and glutathione conjugates.

To learn more, please visit the website: http://eurekaselect.com/journal/72

Bentham Science has entered into a collaboration with the Cyprus Biological Society (CBS) for its flagship journal, Current Medicinal Chemistry (JCR IF: 4.53). This collaboration facilitates members of the society to publish their research in Current Medicinal Chemistry with significant concessions on the Article Processing Charges. The members also get the opportunity to avail discount on personal subscription for the journal.

The Cyprus Biological Society (CBS) was set up in 1978 which makes it one of the oldest scientific societies in Cyprus. Prominent scientist from the field of Biology and many top-ranked government officials have served in various capacities in CBS including Federal Ministers, Members of Parliament, Commissioners, Members of the Education Services Committee, Department Directors of various Ministries, Directors of Research Organization, Institute Directors, Presidents of Community Councils, Directors of Environment Centers for Education and Research and other important positions. To learn more about the society, please visit: https://www.cbs.cy/en/homepage-english/

Bentham Science Publishers is a major international science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide. Bentham Science journals are indexed in recognized indexing agencies and information on our journals’ indexation, by various indexing agencies, can be viewed at https://eurekaselect.com

About Current Medicinal Chemistry:

Current Medicinal Chemistry covers all the latest and outstanding developments in the field of medicinal chemistry. It also includes topics related to quantitative structure-function relationships, drug absorption, drug distribution, drug metabolism, new and emerging drug targets, pharmacogenomics, drug discovery toxicology, high-throughput screening, combinatorial chemistry, structural characterization and organic syntheses of naturally occurring compounds, as well as chemical and analytical techniques used in rational drug design. Each issue incorporates a series of timely in-depth/mini-reviews and guest-edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents.

Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be informed and up-to-date with the latest and most important developments relevant to their field.

For more information, please visit: http://eurekaselect.com/journal/25

Bentham Science is pleased to welcome the Italian institution, University of Genova, as a Read and Publish subscriber. Through the partnership the faculty, library and others affiliated with the university can access the Bentham Chemistry Collection of journals, articles and books, including archival access to the older volumes of the titles. The subscription also provides the opportunity to the associated authors and researchers from the university to publish their research under an Open Access license, free of any Article Processing Charges.

The University of Genova (UniGe) is one of the largest universities in Italy. It is located in the city of Genoa, on the Italian Riviera in the Liguria region of northwestern Italy. It comprises five schools having twenty-two departments that cover studies and research in various fields of applied sciences, medical and pharmaceutical sciences, engineering, information technology and social & humanitarian sciences among other fields. The University of Genova is currently ranked as the 278^th best university globally, whereas in Europe and its country of origin, Italy, the university stands at 119^th and 10^th ranks respectively.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide. Bentham Science currently publishes more than 170 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences.

26 more books from our catalog have recently been included in the Web of Science Core Collection® which is one of the world's leading reference databases for scholarly content. Here is a list of books indexed in the database. We congratulate all editors, authors and reviewers for their contributions to these works and look forward to publishing more impactful books in the future.

Bentham Science is pleased to announce that Current Green Chemistry journal has been indexed in Cabells Journalytics. Bentham Science would like to congratulate all scholarly contributors involved with the journal.

Current Green Chemistry was launched in the year 2013, and since its inception, the journal has been publishing original research, full-length/mini reviews and thematic issues in all core areas of green chemistry. The scope of the journal covers research studies related to synthetic chemistry, process and analytical chemistry, separation science, sustainable resources, and alternative environmentally safer chemical procedures, related to green chemistry.

Learn more about the journal here: http://www.eurekaselect.com/journal/141

Cabells Journalytics curates list of over 11,000 academic journals spanning 18 disciplines. Since its founding, the journal has expanded its services to include systems for identifying both journalytics and predatory journals, among other services.

Bentham Science is pleased to announce that Current Radiopharmaceuticals is now indexed in Science Citation Index Expanded (Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging) for the year 2021, onwards. Bentham Science would like to congratulate all scholarly contributors involved with the journal.

Since its inception in 2008, Current Radiopharmaceuticals has been communicating information about research and developments about radiolabeled compound preparations used for studies in nuclear medicine, molecular imaging, radionuclide therapy, and basic research in natural sciences. The journal is of interest to readers interested in advances in radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research, and medical applications (radiology, oncology and radiotherapy). Current Radiopharmaceuticals will continue to deliver impactful research in the field to readers around the world and we look forward to seeing the journal gain recognition among the top journals in the respective fields in the time ahead.

Learn more about the journal here: https://www.eurekaselect.com/journal/95

Science Citation Index Expanded™ (Powered by Clarivate) indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. Clarivate’s expert in-house editors select the most influential journals in their respective fields according to a set of 28 criteria that help them determine scholarly quality and impact.

Bentham Science has entered into a collaboration with Spanish Society of Pharmacology (SEF) for our High Impact journals including Current Neuropharmacology (JCR IF: 7.36), Current Medicinal Chemistry (JCR IF: 4.53), Current Topics in Medicinal Chemistry (JCR IF: 3.295) , and Current Pharmaceutical Design (JCR IF: 3.116) . This collaboration facilitates members of the society to publish their research in Bentham journals with significant concessions.

The SEF was founded in 1972 to bring together all Spanish pharmacologists, in order to facilitate organizing scientific meetings (an annual meeting at the national level) with the aim of promoting scientific and social exchange among Spanish pharmacologists as well as joint meetings with other Pharmacology Societies within the framework of the International Pharmacology Association and the European Pharmacology Association (IUPHAR and EPHAR). The Society represents researchers in national and international organizations, helps networking at scientific and technical meetings, awards scholarships and prizes to stimulate pharmacological research in Spain. In addition, it manages the operation of different working committees reviewing specific issues in pharmacology and allied research.

Bentham Science Publishers is a major international science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.

Bentham Science currently publishes more than 130 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies and Information on our journals’ indexation, by various indexing agencies, can be viewed at https://eurekaselect.com/.

Clarivate has recently published the latest edition of Journal Citation Reports^TM providing information for the category ranking and Impact Factor ratings of indexed journals in 2020. Bentham Science journals have performed well and received good Impact Factor rankings this year. 35 out of our 40 ranked journals have secured a higher Impact Factor, while 5 journals have, more or less, maintained their ratings.

Current Neuropharmacology has proved to be the most impactful title from our catalog again over the last year in terms of publishing quality research that has been readily cited by the researchers worldwide. Its Impact Factor has increased to 7.363 from 4.668 In the previous period.

Other highlights in the report include Current Gene Therapy (Impact Factor 2020: 4.391) and Recent Patents on Anti-Cancer Drug Discovery (Impact Factor 2020: 4.169), which have received an appreciable increase in Impact Factors.

Bentham Science congratulates all of its contributors and looks forward to raising the bar on publishing impactful research for the benefit of the global scientific community.

Here is the list of all of Bentham’s Impact Factor journals.

Bentham Science has joined the Membership Program offered by ORCID to facilitate its stakeholders including the authors, Editorial Board Members, and their affiliating institutions. Through the ORCID Membership, Bentham Science endeavors to ensure that the researchers have a trustable connection with their published works, research profiles and their affiliations.

ORCID has become a critical part of the digital infrastructure needed for researchers to share information on a global scale. The organization enables transparent and trustworthy connections between researchers, their contributions, and their affiliations by providing a unique identifier (an “ORCID ID”) associated with an ORCID record for individual researchers to use as they engage in research, scholarship, and innovation activities.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information. Bentham Science currently publishes more than 100 journals in both electronic and printed formats. Bentham Science journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies, including Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, and EMBASE.

For more information about the membership, please visit: https://orcid.org/members/0016f00002YcGmaAAF-bentham-science

Bentham Science announces the launch of the subscription-based journal, Current Functional Foods . The first issue of the journal will be available online in the year 2021.

Dr. Adriano Mollica is the Editor-in-Chief of this new journal. He is affiliated with the University of G. d'Annunzio Chieti and Pescara, Italy. Dr. Azzurra Stefanucci from the University of G. d'Annunzio Chieti and Pescara, Italy, serves as the Co-Editor for the journal.

“ Current Functional Foods ” aims to publish cutting edge research in the field of foods and food ingredients with health benefits.

The journal focuses on functional foods with emphasis on food chemistry technology, nutrition and health. Reviews and research papers with an interdisciplinary approach are welcomed. The journal covers the fields of bioactive plants used for nutrition, dietary fiber, probiotics; functional lipids; bioactive peptides; vitamins, minerals and botanicals and other dietary supplements. Experimental works dealing with food digestion, bioavailability of food bioactives and the mechanisms by which foods and their components are able to modulate physiological parameters connected with disease prevention of dysmetabolism will be considered for publication. The areas covered include new food bioactives, efficacy and toxicology of bioactive compounds, and other healthy food constituents. The use of genomic, chemical and biochemical technologies for study of such materials is included.

For more information about the journal please visit https://eurekaselect.com/journal/204

Bentham Science is pleased to announce an Institutional Member Partnership with the Turkish university, Çukurova University Tropical Diseases Research and Application Center (TDRAC). The partnership provides the opportunity to the researchers, from the university, to publish their research under an Open Access license with specified fee concessions. This agreement is a continuation of Bentham Science Publishers' vision to make transformative agreements with renowned institutions around the world and facilitate their researchers for publishing their research.

The Tropical Disease Research and Application Center (TDRAC) was founded by Çukurova University and officially approved by “Turkiye Institution of Higher Education” in 1984. TDRAC has been involved in research studies on the diagnosis, molecular epidemiology, and detecting vectors of regional tropical and subtropical diseases like Leishmania, Tuberculosis, Malaria, and Amoebiasis. The center also conducts training for laboratory diagnosis and new and educational treatments since its foundation.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Bentham Science currently publishes more than 130 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing services, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, and EMBASE.

Bentham Science is pleased to announce an Institutional Member Partnership with the Portuguese university, Universidade Lusófona. The partnership gives researchers from the university an opportunity to publish their research under an Open Access license under economical terms. This agreement is a continuation of Bentham Science Publishers' vision to make transformative agreements with renowned institutions around the world and facilitate their researchers for publishing their work.

Universidade Lusófona de Humanidades e Tecnologias (Lusophone University of Humanities and Technologies) is the largest Portuguese private university, and the main institution of Grupo Lusófona, which administers other universities and colleges in Portugal, Brazil, Cape Verde, Angola, Guinea-Bissau and Mozambique. Promotion of Lusophony (the speaking of Portuguese) is seen as a major objective of the institution.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Bentham Science currently publishes more than 130 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing services, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, and EMBASE.

Bentham Science is pleased to announce a partnership with the German consortium ‘Specialized Information Services for Science’ Pharmacy (Fachinformationsdienst Pharmazie FID PubPharm) for a ‘Read and Publish’ Agreement. The consortium comprises of 23 leading German universities. The partnership allows the library patrons from the universities who partake in FID Pharmacy, to access licensed Bentham Science journals and in parallel to give the researchers from the universities an opportunity to publish their research under an Open Access license at discounted rates.

The ‘Specialized Information Services for Science’ (Fachinformationsdienst FID) is a funding program for scientific libraries of the German Research Foundation (Deutsche Forschungsgemeinschaft DFG), which aims to strengthen and improve information infrastructures for research. It forms the further development of the special collection areas at academic libraries in Germany that have been funded since 1949. Some of the reputable universities in FID Pharmacy consortium include Freie Universität Berlin, Ludwig Maximilians Universität München, Friedrich Schiller Universität Jena and others.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Bentham Science currently publishes more than 120 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing services, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, and EMBASE.

Current Nanomedicine journal, published by Bentham Science Publishers, has been accepted for inclusion in Scopus. Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings.

Current Nanomedicine publishes full-length/mini reviews, research articles and guest edited thematic issues in the field of nanomedicine. The journal is essential reading for all academic, industrial and clinical researchers who wish to be kept informed about important breakthroughs in nanomedicine.

For more information about the journal, please visit: http://www.eurekaselect.com/journal/161

Bentham Books, the books publishing division of Bentham Science, is pleased to announce that the indexing service, Book Citation Index (Web of Science), has accepted to index the following three more books published by the publisher. The Book Citation Index (BCI, BKCI) is an online subscription-based scientific citation indexing service maintained by Clarivate Analytics and is part of the Web of Science Core Collection.

Web of Science has published the latest edition of Journal Citation Reports® on 29th June, 2020, providing information for the category ranking and Impact Factor ratings of the indexed journals in 2019. According to JCR 2020, Bentham Science journals have performed significantly well.

Following is the list of some high impact factor journals published by Bentham Science:

Learn more about Bentham Science Publishers high impact journals here: https://eurekaselect.com/jounral-impacting-science

Current Nanomaterials journal, published by Bentham Science Publishers, has been accepted for inclusion in Scopus. Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings.

Current Nanomaterials , a peer reviewed journal publishes full-length/mini reviews, original research articles and thematic issues on experimental and applied research on nanomaterials. The scope covers the synthesis, structure, properties, characterization and application of nanomaterials. The journal will cover all areas of nanomaterial science, engineering and nanotechnology with emphasis on all aspects of research on a wide range of nanomaterials including nanocomposites, inorganic materials, polymeric and biological materials and hybrid materials.

This inter-disciplinary journal will be of interest to scientists in both the physical and biomedical/pharmaceutical related disciplines in nanoscience research.

For more information about the journal, please visit: https://www.eurekaselect.com/journal/160

THE UNIVERSITY OF BATH AND BENTHAM SCIENCE continue their existing access license agreement and add ‘READ AND PUBLISH’ elements for Bath academic community

Bentham Science and University of Bath are pleased to announce their partnership through the ‘Read and Publish’ Agreement. With this partnership the faculty, library and others affiliated with the university can access the entire host of more than 130 + Bentham Science journals including archival access to the older volumes of all titles. The contract also gives the researchers from the university, an opportunity to publish their research under an Open Access license at discounted rates.

The University of Bath is a public university located in Bath, Somerset, United Kingdom. It received its royal charter in 1966. Over the years, the university has established itself as a top 10 UK university with a reputation for research and teaching excellence. It is ranked as the 6th best university in the UK by the Guardian University Guide 2020. Also, the university is ranked 5th for graduate prospects by The Times and The Sunday Times Good University Guide 2020.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Bentham Science currently publishes more than 130 journals in both electronic and printed formats. These journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing services, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, and EMBASE.

For more information please contact: joost@benthamscience.net.

Bentham Science congratulates Dr. Kenneth Blum, the Editor-in-Chief of the journal, Current Psychopharmacology, for being nominated as ‘The Marquis Who’s Who – Scientist of the Year’.

Established in 1898, Marquis Who’s Who began publishing biographical data in 1899. Since then, Marquis has remained the standard for reliable and comprehensive biographical data. As in all Marquis Who’s Who biographical volumes, profiled individuals are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Kenneth Blum has been nominated as the scientist of the year 2020 for his services in the fields of Pharmacology and NeuroGenetics. Dr. Blum serves as Chairman of Geneus Sciences LLC., His concept of Reward Deficiency Syndrome is being embraced by world leaders in science and is part of the DSM –V, ASAM, Sage Encyclopedia of abnormal and clinical psychology 2017. Dr, Blum is credited with the DRD2 gene discovery and addictive diseases. He serves as Editor-in-Chief in Journal of Reward Deficiency Syndrome (he coined) and Addiction Sciences and Co-EIC of Journal of Neuroimaging in Psychiatry and Neurology (USG). He is currently serving on fourteen other prestigious journal’s Editorial Boards. He has published over 450 articles, 16 books, numerous patents and received many awards (Life-Time Achievements) for his seminal discoveries. He is the founding President of United Scientific Group (USG).

We would also like to acknowledge his contributions for the journal, Current Psychopharmacology.

Frontiers in Natural Product Chemistry [ISSN / E-ISSN: 1574-0897 / 2212-3997], has been accepted for inclusion in Scopus.

Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings.

Frontiers in Natural Product Chemistry is a book series devoted to publishing monographs that highlight important advances in natural product chemistry. The series covers all aspects of research in the chemistry and biochemistry of naturally occurring compounds, including research on natural substances derived from plants, microbes and animals. Reviews of structure elucidation, biological activity, organic and experimental synthesis of natural products as well as developments of new methods are also included in the series. The book series is essential reading for scholars involved in the field of pharmacology, medicinal chemistry and multidisciplinary work involving natural products.

Frontiers in Natural Product Chemistry has currently published 5 volumes under the editorship of Prof. Atta-ur-Rahman, FRS.

More information about the book series can be found here.

The recent COVID-19 outbreak has been the main reason behind several temporary school closures around the world. This has made the idea of continuing to pursue educational activities during this time, a challenging proposition. The current lockdowns, implemented differently in different countries, have forced schoolteachers, who wish to complete their current teaching periods, to transition immediately to the online classroom. Many schools have already started online classes in the wake of the crisis caused by the global COVID-19 crises. Accessing and managing online teaching resources can be a bit difficult for educators or pupils accustomed to a conventional classroom.

A couple of our authors reached out to us and asked if Bentham Science had a solution for their book, Computer Based Projects for a Chemistry Curriculum - which is a great resource for school and college students and teachers interested in using computers to illustrate fundamental concepts in chemistry. And we have responded. Starting today, up to June 30, Bentham Science Publishers is making the e-book, free to download. This means that high school teachers and students anywhere in the world can access the content and benefit from the projects presented in the book.

Computer Based Projects for a Chemistry Curriculum, authored by Thomas Manning and Aurora Grumatges, presents 24 chapters; each giving information about activities employing applications such as MS excel (spreadsheets) and Spartan (computational modeling). Each project is explained in a simple, easy-to-understand manner. The content within this book is suitable as a guide for both teachers and students and each chapter is supplemented with practice guidelines and exercises. The book contents can be accessed here:

http://www.eurekaselect.com/108744/volume/1

We hope that students around the world can benefit from the interesting and informative variety of projects presented in the book, while also allowing educators working in schools, to continue their teaching activities throughout the academic year amidst the current pandemic crisis. Stay safe, and happy chemistry learning.

Bentham Science announces an important new journal, “Coronaviruses” to cover the latest research on coronavirus- related outbreak and the methods employed to treat coronavirus infections. Every article in the first issue of the journal will be published as Open Access (Free-to-download) for a limited time period of three months.

The Editor-in-Chief of the journal is Prof. Jean-Marc Sabatier, who serves at the Institute of NeuroPhysiopathology Marseille, Cedex, France. The Honorary Editors of the journal are Prof. Ferid Murad (Nobel Laureate) and Prof. Atta-Ur-Rahman, FRS (Academician Chinese Academy of Sciences, and UNESCO Science Laureate).

Coronaviruses will publish original research articles, letters, reviews/mini-reviews and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc. The Journal will also cover case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment regimens and development of new drugs.

The journal will be essential reading for virologists, epidemiologists, microbiologists and healthcare workers interested in the latest information about coronaviridae.

Visit the journal website for more details: https://benthamscience.com/journals/coronaviruses/

Bentham Science announces an important new multidisciplinary journal, Current Chinese Science . This will be the world’s largest journal with over 4,000 leading Chinese scientists involved on its editorial board.

Current Chinese Science is a peer reviewed journal with over 70 sections headed by leading Chinese scientists as Co-Editors. The journal will cover important and emerging fields in agriculture, science, engineering, medicine and other areas. The journal aims to provide researchers and scholars a strong platform to publish their work and share their findings with readers around the world. The Honorary Editors of the journal are Prof. Ferid Murad (Nobel Laureate) and Prof. Atta-Ur-Rahman, FRS (Academician Chinese Academy of Sciences, and UNESCO Science Laureate).

The journal will be essential reading for scientists and scholars involved in a variety of scientific disciplines, largely reflecting the tremendous scientific progress being made in China. Every article in the first issue of Current Chinese Science will be published as Open Access (Free-to-download) for a limited time period of three months.

Visit the journal website for further details: currentchinesescience.com

Bentham Science is pleased to announce a partnership with Freie University Berlin for a ‘Read and Publish’ Agreement. The partnership allows the library patrons to access Bentham Science journals and gives researchers from the university an opportunity to publish their research under an Open Access license at discounted rates.

Freie University Berlin is a leading research institution in Germany. It is one of the German universities successful in all three funding lines in the federal and state Excellence Initiative, thereby receiving additional funding for its institutional future development strategy.

Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Bentham Science currently publishes more than 130 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing services, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, and EMBASE.

We bring good tidings!

Bentham Science journals, Current Organic Synthesis and Current Medical Imaging, have been indexed in MEDLINE. MEDLINE is the premier bibliographic database of the U.S. National Library of Medicine® (NLM) that contains more than 25 million references to journal articles relevant to life sciences with a concentration on medicine. MEDLINE is the primary component of PubMed®, part of the Entrez series of databases provided by the NLM National Center for Biotechnology Information (NCBI). For more information, please visit: https://www.nlm.nih.gov/bsd/medline.html

Current Organic Synthesis publishes in-depth/mini reviews, original research articles and letter/short communications on all areas of synthetic organic chemistry i.e. asymmetric synthesis, organometallic chemistry, novel synthetic approaches to complex organic molecules, carbohydrates, polymers, protein chemistry, DNA chemistry, supramolecular chemistry, molecular recognition and new synthetic methods in organic chemistry.

Current Medical Imaging publishes frontier review articles, original research articles, case reports, drug clinical trial studies and guest edited thematic issues on all the latest advances on applied medical imaging in clinical research.

We look forward to increased paper flow of high quality articles in these journals.

Bentham Science congratulates Prof. Dr. Atta-ur-Rahman, FRS for being selected for the award, 'China International Science and Technology Cooperation Award', by NOSTA (National Office for Science & Technology Awards) for the year 2020. NOSTA has selected Prof. Dr. Atta-ur-Rahman for the award to acknowledge his numerous contributions in the field of chemistry. Prof. Atta-ur-Rahman has a longstanding relationship with Bentham Science as the founding Editor-in-Chief for its high impact journal, Current Medicinal Chemistry. This top international award has previously been given to several leading scientists of the world including the Nobel Laureates, Dr. Carlo Rubbia (Nobel Prize in physics, 1984) and Dr. Zhores I. Alferov (Nobel Prize in physics, 2000). He is an Academician of Chinese Academy of Sciences and Fellow of Royal Society (London).

Prof. Atta-ur-Rahman is author/editor of over 1,250 international publications including 341 books largely published by major US and European presses on the basis of which he has been awarded honorary doctorate degrees by many top universities including the University of Cambridge (UK). He has won the highest civil Awards from Austria and China and was elected Honorary Life Fellow of Kings College, Cambridge university. A number of research institutions have been named in his honour in China and Malaysia.

Starting from 15 Dec 2019 till 29 Feb 2020, Bentham Science Publishers is offering a substantial discount on publications:

All books and PPV journal articles ordered or purchased during this period will be discounted for 30%.

Readers can choose any book from our catalog of over 850 Books in a variety of scientific fields from our catalog list here.

Our PPV articles are categorized by disease and can be viewed here.

To avail these discounts, simply use the code BSPPRC283 on our e-store (www.eurekaselect.com) when purchasing your books or articles. There is no limit to the number of discounted books or articles you can purchase.

For more information on this offer or to place your order, contact us at marketing@benthamscience.net.

Hunan University of Chinese Medicine (HUCM) has established the Academician Professor Atta-ur-Rahman One Belt and One Road TCM Research Center at its main campus at Changsha, the capital city of Hunan province in China.

The inaugural ceremony for the research center was conducted on October 24, 2019, along with Annual Bio-TCM International Conference at HUCM. Dr. Wei Wang, Professor at Hunan University of Chinese Medicine, stated on behalf of the university.

"The University recognizes the contributions of Prof. Dr. Atta-ur-Rahman in the field of traditional medicine. This center is indeed a humble recognition of Prof. Atta-ur-Rahman's tremendous scientific contributions in the field of traditional medicine, and his leadership of developing scientific collaboration between the two countries."

Prof. Atta-ur-Rahman has a longstanding association with Bentham Science as the Editor in Chief of Current Medicinal Chemistry, a leading journal in the field of medicinal chemistry.

Dr. Atta-ur-Rahman, FRS , is the Editor for Current Medicinal Chemistry. Dr. Rahman won the UNESCO Science Prize and was elected Fellow of the Royal Society (London). He was conferred honorary doctorate degrees by many universities including Cambridge University. He was elected Honorary Life Fellow of King's College, Cambridge University, and the Austrian government honoured him with its high civil award (“Grosse Goldene Ehrenzeischen am Bande") (2007) .He is Foreign Fellow (“Academician”) of Chinese and Korean Academy of Sciences.

Current Medicinal Chemistry (Impact factor 3.46), is one of the inaugural publications of Bentham Science Publishers. Now in its 26th volume, the journal continues to publish frontier reviews in the field, enabling researchers to stay at the forefront of pharmaceutical design, discovery and synthesis. More information about the journal can be found here.

Bentham Science is pleased to announce the launch of the Open Access journal,  New Emirates Medical Journal . The first issue of the journal, by Bentham Science, will be available online by the start of the year, 2020.

Dr. Abdullah Shehab is the Editor-in-Chief of this new journal. Dr. Abdullah Shehab serves as the General Secretary of the Emirates Cardiac Society.

New Emirates Medical Journal (NEMJ) formally known as Emirates Medical Journal (EMJ) is an official journal of the Emirates Medical Association (EMA), UAE, is an Open Access online journal. The NEMJ publishes original research, clinical reports, case studies, short research communications, reviews, book reviews, correspondence, and editorials. An exclusive platform “Student Forum” for aspiring medical students and post-graduate students is provided to encourage student submissions in all the medical specialties including pre-clinical, para-clinical, and clinical subjects, medical education, clinical management and various aspects of medicine and public health.

Each peer-reviewed article that is published in the New Emirates Medical Journal is universally and freely accessible via the Internet in an easily readable and printable PDF format.

For more information about the journal, please visit: https://benthamscience.com/journals/new-emirates-medical-journal/.

Bentham Science announces the launch of the subscription-based journal,  Current Nanotoxicity and Prevention . The first issue of the journal will be available online by the mid of the year, 2020.

Dr. Rajendra Susai is the Editor-in-Chief of this new journal. Dr. Rajendra Susai has been serving as Professor of Chemistry at RVS School of Engineering and Technology.

Current Nanotoxicity and Prevention aims to provide an interdisciplinary forum for researchers and practitioners, to share innovative research and engineering practices that prevent nano-toxicity.

The journal also aims to explore how innovative methods are used for detection, evaluation and mitigating nanotoxicity. In addition, new safety regulations for manufacturer/application/disposal/exposure of nanomaterials will be proposed in the journal.

For more information about the journal, please visit: https://benthamscience.com/journals/current-nanotoxicity-and-prevention/.

Bentham Science announces the launch of the subscription-based journal,  Current Mechanics and Advanced Materials . The first issue of the journal will be available online by the mid of the year, 2020.

Dr. Q. H. Qin is the Editor-in-Chief of this new journal. Dr. Q. H. Qin is Professor of Materials and Manufacturing Group at The Australian National University.

 Current Mechanics and Advanced Materials is an international journal devoted to publishing peer-reviewed, high quality, original papers in the field of Materials science. The following article types are published: original research articles, reviews, thematic issues, editorials, letters, and conference reports.

For more information about the journal, please visit: https://benthamscience.com/journals/current-mechanics-and-advanced-materials/.

Bentham Science Publishers, a publisher of over 100 scholarly journals and more than 800 books, aims to promote research in all the facets of science, technology and medicine. With this aim, we partner and attend scientific conferences worldwide and promote their agenda, the topics being presented and the salient speakers in the conferences.

The recent events Bentham Science is attending, include:

FRANKFURT BOOK FAIR

To view the information for all the upcoming events, please visit: https://benthamscience.com/exhibit-schedule.php

Bentham Science Publishers is pleased to announce that the journal Endocrine, Metabolic & Immune Disorders - Drug Targets (EMIDDT) is now the official journal of Associazione Medici Endocrinologi (AME), / Italian Medical Endocrinology Association. The journal is currently edited by Prof. Emilio Jirillo (University of Bari, Italy). Bentham Science Publishers wishes both the EMIDDT editorial board and AME society members a successful collaboration.

About AME

Associazione Medici Endocrinologi (AME) is a professional society born from the need to bring together those who work daily in the field of clinical endocrinology in Italy. AME promotes initiatives aimed at a constant growth of endocrinology as a discipline by improving medical guidelines, organizing meetings, developing cognitive tools for healthcare professionals and facilitating the publication of relevant research. Learn more about AME here.

About EMIDDT

Endocrine, Metabolic & Immune Disorders - Drug Targets (EMIDDT) journal is devoted to full-length/ mini reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome. Find out more about the journal here.

We are pleased to announce the selection of 77 Bentham book titles by Clarivate Analytics for coverage in the Web of Science™ Core Collection platform. This addition extends our existing list of indexed books and reflects upon the sustained quality of our book titles in a broad range of fields in life sciences, engineering and social sciences. We wish to congratulate our eminent editors and authors on their hard work.

Here is the list of the indexed books:

Scopus has recently included the eBook, “Frontiers in Clinical Drug Research - Anti Infectives”, for coverage in its database. Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings.

Frontiers in Clinical Drug Research – Anti Infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases.

For more information please visit: https://benthambooks.com/book/9781608058549/.

‘Frontiers in Clinical Drug Research - Anti Allergy Agents’, book published by Bentham eBooks, has been accepted for inclusion in Scopus

Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings.

Frontiers in Clinical Drug Research - Anti-Allergy Agents is an exciting book series comprising a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The first volume of this series sheds light on new therapies that can be employed for allergic reactions in patients (both traditional and non-traditional therapies), nutrition based therapies and the use of substances such as omalizumab and adrenaline to counter inflammatory response and anaphylaxis in patients.

For more information about the book, please visit: https://www.eurekaselect.com/node/114946/frontiers-in-clinical-drug-research-anti-allergy-agents.

Pharmaceutical Nanotechnology journal, published by Bentham Science Publishers, has been accepted for inclusion in Scopus. Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings.

Pharmaceutical Nanotechnology publishes original manuscripts, full-length/mini reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale.

For more information about the journal, please visit: https://benthamscience.com/journals/pharmaceutical-nanotechnology/.

Bentham Science is pleased to announce the launch of new subscription-based journal, Current Chinese Computer Science . The first issue of the journal will be available online by the start of the year, 2020.

Professor Wenwu Yu is the Editor-in-Chief of this journal. Prof. Yu is currently the Young Endowed Chair Professor at the School of Mathematics and School of Cyber Security in Southeast University, China.

Dr. Ferid Murad (Nobel Laureate) and Dr. Atta-ur-Rahman (FRS) join the editorial board of Current Chinese Computer Science as honorary advisors for the journal. For information about the Editorial Board of the journal, please visit: https://benthamscience.com/journals/current-chinese-computer-science/editorial-board/.

Current Chinese Computer Science  publishes original research articles, letters, reviews/mini-reviews and guest edited thematic issues on various topics related to computer science in China and other countries.

Current Chinese Computer Science  is not limited to a specific aspect of the field but is devoted to a wide range of sub fields of computer science. Articles of interdisciplinary nature are particularly welcome. Submission in the following areas are of special interest to the readers of this journal: Computer Engineering, Theoretical Computer Science, Machine Learning, Communication and Security, Telecommunications Engineering, Artificial Intelligence, Evolutionary Computing/Quantum Computing, Relational Databases, Software Engineering, Computer Vision and other relevant areas.

For more details, please visit the journal homepage: https://benthamscience.com/journals/current-chinese-computer-science/

Bentham Science is pleased to announce the launch of new subscription-based journal, Current Chinese Engineering Science . The first issue of the journal will be available online by the start of the year, 2020.

Dr. G.Y. Jin is the Editor-in-Chief of this new journal. Dr. Jin serves as Professor at College of Power and Energy Engineering, Harbin Engineering University.

Dr. Ferid Murad (Nobel Laureate) and Dr. Atta-ur-Rahman (FRS) join the editorial board of Current Chinese Engineering Science as honorary advisors for the journal. For information about the Editorial Board of the journal, please visit: https://benthamscience.com/journals/current-chinese-engineering-science/editorial-board/.

Current Chinese Engineering Science  publishes original research articles, letters, case reports, reviews/mini-reviews and guest edited thematic issues on various topics related to engineering in China and worldwide.

Current Chinese Engineering Science  is not limited to a specific aspect of the field but covers a vast subject areas in engineering. Submission in the following areas are of special interest to the readers of this journal: Aerospace Engineering, Chemical Engineering, Applied Engineering, Ceramics Engineering, Industrial Engineering, Nuclear Engineering, Biological Engineering, Electrical Engineering, Materials Engineering, Offshore Engineering, Civil Engineering, Financial Engineering, Mechanical Engineering etc.

For more details, please visit the journal homepage: https://benthamscience.com/journals/current-chinese-engineering-science/

Bentham Science is pleased to announce the launch of new subscription-based journal, Current Chinese Medical Science . The first issue of the journal will be available online by the start of the year, 2020.

Dr. Yanmin Zhang is the Editor-in-Chief of this journal. Dr. Zhang serves as Professor of School of Pharmacy, Health Science Center, Xi'an Jiaotong University of China.

Dr. Ferid Murad (Nobel Laureate) and Dr. Atta-ur-Rahman (FRS) join the editorial board of Current Chinese Medical Science as honorary advisors for the journal. The information for the Editorial Board of the journal can be viewed here: https://benthamscience.com/journals/current-chinese-medical-science/editorial-board/.

Current Chinese Medical Science publishes original research articles, letters, case reports, reviews/mini-reviews and guest edited thematic issues dealing with various topics related to medical science in China and worldwide.

Current Chinese Medical Science  is not limited to a specific aspect of the field but is instead devoted to a wide range of sub fields in the field. Articles of interdisciplinary nature are particularly encouraged for submission. Submission in the following areas are of special interest to the readers of this journal: Cardiology and Cardiovascular Medicine, Hypertension, Oncology, Genetics, Endocrinology, Nuclear medical science, Cell and Molecular Biology and other related topics.

For more details, please visit the journal homepage: https://benthamscience.com/journals/current-chinese-medical-science/

Bentham Science is pleased to announce the launch of new subscription-based journal, Current Chinese Chemistry . The first issue of the journal will be available online by the start of the year, 2020.

Professor Huan-Tsung Chang is the Editor-in-Chief of this journal. Prof. Chang is a Distinguished Professor in the Department of Chemistry, National Taiwan University and Adjunct Chair Professor in the Department of Chemistry, Chung Yuan Christian University.

Dr. Ferid Murad (Nobel Laureate) and Dr. Atta-ur-Rahman (FRS) join the editorial board of Current Chinese Chemistry as honorary advisors for the journal. The information about the Editorial Board of the journal can be viewed here: https://benthamscience.com/journals/current-chinese-chemistry/editorial-board/.

Current Chinese Chemistry will publish original research articles, letters, reviews/mini-reviews and guest edited thematic issues dealing with various topics related to chemistry in China, and other countries..

Current Chinese Chemistry covers a wide range of subjects in Chemistry, including, Physical Chemistry, Bioorganic Chemistry, Inorganic Chemistry, Biochemistry, Bioinorganic Chemistry, Environmental Chemistry, Organic Chemistry, Organometallic Chemistry, Medicinal Chemistry, Supramolecular Chemistry, Spectroscopy, Green Chemistry and Materials Chemistry.

For more details, please visit the journal homepage: https://benthamscience.com/journals/current-chinese-chemistry/

Bentham Science is pleased to announce the launch of new subscription-based journal, Current Nutraceuticals . The first issue of the journal will be available online by the start of the year, 2020.

Dr. Claus Jacob is the Editor-in-Chief of this journal. He serves as Professor in the School of Pharmacy, Saarland University, Saarland, Germany. For brief information about the Editorial Board of the journal, please visit: https://benthamscience.com/journals/current-nutraceuticals/editorial-board/.

Current Nutraceuticals publishes original research articles, mini- and full-length reviews, feature articles, technical notes and thematic issues covering all aspects of nutraceuticals, from the isolation and comprehensive characterization of secondary metabolites and their synthesis to the biological activity of nutritional constituents and antioxidants, clinical, population, ethnological and agricultural studies. The journal also explicitly welcomes interdisciplinary contributions considering wider social, cultural, ethical and applied aspects of nutraceuticals and nutrition in modern society.

For more details, please visit the journal homepage: https://benthamscience.com/journals/current-nutraceuticals/

Bentham Science is pleased to announce the launch of new subscription-based journal, Venoms and Toxins . The first issue of the journal will be available online by the start of the year, 2020.

Dr. Jean-Marc Sabatier is the Editor-in-Chief of this journal. Dr. Sabatier is the Director of Research at the French CNRS. Dr. Sabatier holds PhD and Habilitation A Diriger Des Recherches (HDR) degrees in Biochemistry and Microbiology. He is also the Chief Scientific Officer of Tournoux Biotech, France. For information about the Editorial Board of the journal, please visit the editorial board page here: https://benthamscience.com/journals/venoms-and-toxins/editorial-board/.

Venoms and Toxins publishes up-to-date review articles, research articles, thematic issues, short communications, and case reports covering all aspects of toxins, venomous animals (e.g. scorpions, snakes, sea anemones, cone snails, worms, wasps and frogs) and their derivative products.

The journal is devoted to the many aspects of marine and non-marine toxins/molecules (and derivatives thereof) from animal venoms, including their structural characteristics, structure-function relationship, pharmacological and immunological properties, molecular engineering/drug design, biotechnological potential, and therapeutic value. The journal also covers all aspects of other types of toxins (including toxic substances of non-protein/peptide origin), such as plant/algae, viral and bacterial toxins.

For more details, please visit the journal homepage: https://benthamscience.com/journals/venoms-and-toxins/

Bentham Science is pleased to announce the launch of a new subscription-based journal, Journal of Photocatalysis . The first issue of the journal will be available online by the start of the year, 2020.

Dr. Leonardo Palmisano is the Editor-in-Chief of this journal. He is Professor of Chemistry at the University of Palermo, Department of Chemical Engineering of Processes and Materials. For information about the Editorial Board of the journal, please visit the editorial board page here: https://benthamscience.com/journals/journal-of-photocatalysis/editorial-board/.

Journal of Photocatalysis will publish high quality research papers, reviews, and short communications focused on photocatalysis from many different scientific areas including Chemistry, Chemical Engineering, Materials Science, Materials Engineering, Environmental Engineering, Nanotechnology and Green Chemistry.

For more details, please visit the journal homepage: https://benthamscience.com/journals/journal-of-photocatalysis/

Bentham Science is pleased to announce the launch of new subscription-based journal, Current Dentistry. The first issue of the journal is available online and can be obtained from: https://benthamscience.com/journals/current-dentistry/

Prof. Alvaro Della Bona is the Editor-in-Chief of this journal. He is a Senior Professor and Dean of Dental School, University of Passo Fundo, Brazil. The information for the Editorial Board of the journal can be viewed from: https://benthamscience.com/journals/current-dentistry/editorial-board/.

Current Dentistry , a peer-reviewed journal, publishes original research, expert reviews, and thematic issues in all areas of dental, oral and craniofacial sciences including biological, clinical, materials engineering and bioengineering aspects of dental research. The journal will be of interest to researchers, healthcare professionals and medical / dental professionals.

For more details, please visit the journal homepage: https://benthamscience.com/journals/current-dentistry/

The latest edition of Journal Citation Reports ® 2019 has been published recently, and according to the report, Bentham Science Publishers (BSP) journals have significantly improved their Impact Factors. Current Neuropharmacology is leading the list again with the highest impact factor (IF: 4.568) among all the journals. In total, 40 BSP journals have received Impact Factor ratings this year. The latest results in the JCR 2019 reflect the high quality of research published by Bentham Science.

Here are the top 10 high impact factor journals published by Bentham Science:

Journal Citation Reports (JCR) is an annual publication by Clarivate Analytics. JCR has been integrated with the Web of Science and is accessible from the Web of Science-Core Collections. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data.

Bentham Science publishes over 100 print & online scholarly subscription journals and books. Learn more about Bentham Science here.

Prof. Lahiri (Professor of Neurobiology, Indiana University School ) Editor-in-Chief of the Bentham Science journal "Current Alzheimer Research" (IF: 3.289) recently gave an interview to the Press team of Indiana University School of Medicine regarding his team’s research on the role of miRNAs against Alzheimer’s disease.

He described in detail the work done in his lab on the role of microRNAs (non-coding RNA molecules that regulate protein production) in Alzheimer’s disease. In the interview, Lahiri described the functions of microRNAs, and the importance of their findings to the research community involved in developing new strategies to treat the disease.

“Alzheimer’s disease occurs when there is a buildup of amyloid-beta peptide in plaque (APP) in the brain,” explained Lahiri. “Why these plaques form remains a mystery, but finding ways to regulate and disrupt these plaques is where our research begins.” One of the normal functions of APP is removing excess iron from cells, which is believed to limit the formation of plaques. Lahiri’s team discovered activity in miR-346, a unique microRNA molecule which is involved in up-regulating the production and subsequent buildup of APP in conjunction with iron responsive elements. These findings suggest that a healthy amount of iron, APP and RNA complexes (a combination called FeAR) must exist to maintain APP homeostasis, which in turn is necessary for keeping the brain healthy. With further research, the team hopes to learn more about miR-346 signaling and how the findings can be applied to future patients in the clinic.

The interview can be read here:

‘Stem Cell and Regenerative Medicine Research’, book series published by Bentham eBooks, has been accepted for inclusion in Scopus. Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings.

Stem cell and regenerative medicine research is a hot area of research which promises to change the face of medicine as it will be practiced in the years to come. Challenges in the 21st century to combat diseases such as cancer, Alzheimer and related diseases may well be addressed employing stem cell therapies and tissue regeneration. Frontiers in Stem Cell and Regenerative Medicine Research is essential reading for researchers seeking updates in stem cell therapeutics and regenerative medicine.

For more information, please visit: https://benthambooks.com/book-series/23527633/

Extend the scope and visibility of your research by creating an animated abstract. Bentham Science has collaborated with Focus Medica, one of the world’s largest publishers of expert animated atlases and videos in medicine and science.

An animated abstract will help summarize the essential discoveries/ key findings of the authors’ published research or review article. Each professionally produced full-colored animated abstract in video format (length 3 – 5 minutes) is accompanied by an English spoken or foreign language commentary. The animated abstract will be published online along with the published article.

Animated abstracts provide added value to published content by means of a visual presentation using narration (in any language), audiovisual resources, graphs, flow diagrams, images and animation. Bentham Science is at the forefront of publishing offering authors such unique video abstracts.

Authors will be asked whether they wish to opt-in for this paid service, and if not, the article will be published without a video abstract. Animated abstracts are available as open access (free viewing) for maximum visibility and awareness to readers at anytime, anywhere. The animated abstracts are licensed under the terms of the Creative Commons Attribution – Non-Commercial-No-Derivatives 4.0 International Public License (CC BY-NC-ND 4.0) https://creativecommons.org/licenses/by-nc-nd/4.0/

For a sample of an animated abstract, please access here www.eurekaselect.com/video.html

About Bentham Science Publishers:

Bentham Science is a science, technology, and medical publisher that publishes over 130 scholarly journals and over 800 Books. Publications from Bentham Science helps academic researchers and industrial professionals get the latest information in diverse fields of science and technology. The peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.

For more information, please visit: https://benthamscience.com/

About Focus Medica:

Focus Medica, a digital publisher, is committed to simplifying health and medical education. It is over a decade since Focus Medica took the first tentative steps into the nascent field of digital publishing. Focus Medica, one of the first publishers to provide digital content by successfully exploiting the vast potential of 3D animations has conceived over 400 innovative digital titles in Medicine and Health that communicate intricate and complex biological concepts.

With the traditional print world adapting to the electronic media, the logical step forward is the audio-visual medium. Focus Medica understands the complexities of electronic media in this digital age and has the in-depth knowledge and expertise to translate print into visual media with the right creative platforms.

Focus Medica's content is created and edited by medical experts in the respective field of medicine.

For more information, please visit: www.focusmedica.com

Dr. Bimal K. Banik, currently the Editor-In-Chief of Current Microwave Chemistry, Current Organocatalysis and Open Chemistry Journal receives the Life-Time Achievement Award 2018 from the Indian Chemical Society (ICS). The ICS was established by Sir Acharya P. C. Ray in 1924 and it is one of the oldest scientific societies in India and also in the world. The Life Time Achievement Award was inaugurated in 1999 and is awarded in recognition of outstanding contributions by chemistry researchers in the world. Dr. Banik is serving as the Vice President of Research & Education Development of Community Health Systems of South Texas. He has been involved in research, teaching, mentoring, advising and administration in the USA for over 25 years. He was a Tenured Full Professor and President's Endowed Professor at the University of Texas-Pan American. Dr. Banik has been awarded multimillion dollar grants by NIH, NCI and other private research foundations as the Principal Investigator. Importantly, he has published and presented approximately 828 papers and patented several discoveries. His research interests include the synthesis and biological evaluation of natural and non-natural anticancer agents and antibiotics as well as catalytic methods, environmentally friendly chemical reactions and microwave-chemistry. Currently, he is also the Editor-in-Chief of 7 other journals. He has received several awards and recognitions for his outstanding research, teaching, advising, mentoring and academic service at the University, State, National, International and Public levels.

For more information, please visit: http://www.rsc.org/news-events/community/2019/jan/lifetime-achievement-award/

Drug Delivery Letters published by Bentham Science Publishers, has been accepted for inclusion in Scopus. Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings.

Drug Delivery Letters publishes letters, original research papers, mini and full length reviews and guest edited issues in all important aspects of drug delivery, gene delivery, and drug targeting.The journals’ scope covers all the basic and applied research in drug delivery and targeting at molecular and cellular levels and novel delivery systems. The journal also focuses on all innovative aspects of all pharmaceutical dosage forms and the most advanced research on controlled release, bioavailability and drug absorption, nanomedicines and gene delivery, etc. The manuscript submission process is fully electronic to ensure rapid publication of research results.

For more information about the journal, please visit: https://benthamscience.com/journals/drug-delivery-letters

The Emerging Sources Citation Index (ESCI), a new database within the Web of Science by Clarivate Analytics, has accepted to index two journals published by Bentham Science Publishers. The titles are:

The Emerging Sources Citation Index (ESCI) is a new index by Clarivate Analytics, extending the range of publications in Web of Science to include high-quality, peer-reviewed publications of regional importance and in emerging scientific fields. ESCI complements the highly selective indexes by providing earlier visibility for sources under evaluation as part of SCIE, SSCI, and AHCI’s rigorous journal selection process. Inclusion in ESCI provides greater discoverability which leads to increased citations.

Dr. Atta-ur-Rahman, FRS, appointed as Executive Editor for Current Molecular Medicine. Dr. Rahman won the UNESCO Science Prize and was elected Fellow of Royal Society (London). He was conferred honorary doctorate degrees by many universities including Cambridge University. He was elected Honorary Life Fellow of Kings College, Cambridge University, and the Austrian government honoured him with its high civil award (“Grosse Goldene Ehrenzeischen am Bande") (2007) .He is Foreign Fellow (“Academician”) of Chinese and Korean Academies of Sciences..

Current Molecular Medicinal (Impact factor 2.254), is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. More information about the journal can be found here.

The Emerging Sources Citation Index (ESCI) has accepted to index Current Traditional Medicine journal published by Bentham Science Publishers.

The Emerging Sources Citation Index (ESCI) is a new index launched by Thomson Reuters, extending the universe of publications in Web of Science to include high-quality, peer-reviewed publications of regional importance and in emerging scientific fields.

Current Traditional Medicine covers all the aspects of the modernization and standardization research on traditional medicine of the world, e.g. chemistry, pharmacology, molecular mechanism, systems biology, proteomics, genomics, metabolomics, safety, quality control, clinical studies of traditional Chinese, Ayurvedic, Unani, Arabic and other ethnomedicine.

The Editor-in-Chief of Current Medicinal Chemistry , Dr. Atta-ur-Rahman, FRS, welcomes Sir John Bertrand Gurdon, FRS, as the Honorary Advisor to the Current Medicinal Chemistry Editorial Board. Sir Gordon is currently Emeritus Professor at Gurdon Institute, Department of Zoology, University of Cambridge, UK. Sir Gurdon shared the Nobel Prize in Physiology or Medicine with Shinya Yamanaka in 2012 for their pioneering research that led to the discovery of processes that convert mature living cells to stem cells.

Current Medicinal Chemistry (Impact factor 3.46), is one of the inaugural publications of Bentham Science Publishers. Now in its 25^th volume, the journal continues to publish frontier reviews in the field, enabling researchers to stay at the forefront of pharmaceutical design, discovery and synthesis. More information about the journal can be found here.

Researchers from around the world publish articles in Bentham Science journals that cover the hottest topics in medicine, technology and several other fields of science. Many of these articles share news about the potential of new discoveries or scientific efforts which pave new paths for research and development, and bring about breakthroughs for the most critical problems prevailing around us.

We believe that sharing research can make a world of difference . Therefore, our Editors-in-Chief have selected important articles as Editor’s Choice for this section. The chosen articles are free to access and download from anywhere by anyone.

Visit the link to explore selected research and make a world of difference!

The latest edition of Journal Citation Reports® 2018 has been recently published, and according to the report, 40 Bentham Science Publishers (BSP) journals have received Impact Factor ratings. Current Neuropharmacology has continued to top the list with the highest impact factor among all Bentham Science Journals. Current Molecular Pharmacology has also joined the BSP High Impact Journals list with its first JCR Impact Factor rating of 2.481.

Here are the top 10 high impact factor journals published by Bentham Science:

Current Neuropharmacology

Impact Factor: 4.068

Journal Citation Reports (JCR) is an annual publication by Clarivate Analytics. JCR has been integrated with the Web of Science and is accessible from the Web of Science-Core Collections. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data.

Bentham Science publishes over 100 print & online scholarly subscription journals and books. Learn more about Bentham Science here.

Bentham Science has agreed to co-distributing publications published by Focus Medica and Panther Publishers. The agreement expands Bentham’s portfolio of products to include more content suitable for the educational needs of students and teachers at school and college levels as well as general readers. The range of publications includes new video books in the form of animated atlases and dictionaries, and the Encyclopedia of Nobel Laureates (1901-2017).

The co-distribution agreement includes the following books:

Animated Atlas of Oncology (Focus Medica)

Clarivate Analytics has recently included the following eBooks for coverage in the Book Citation Index. The Book Citation Index in Web of Science™ Core Collection connects a library’s book collection to powerful new discovery tools, giving researchers the ability to quickly and easily identify and access the most relevant books.

The list of the indexed books is below:

Soluble Factors Mediating Innate Immune Responses to HIV Infection

To view the entire library of 700+ Bentham eBooks, download our eBook catalog here.

The International Society for the Study of Xenobiotics (ISSX) signs agreement with Bentham Science Publishers to promote the journals, Current Drug Metabolism and Drug Metabolism Letters , among its members. ISSX is the premier scientific organization for researchers interested in the metabolism and disposition of xenobiotics.

Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of timely review articles and guest edited issues in drug metabolism. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism.

Drug Metabolism Letters publishes letters, original research articles, mini-reviews, thematic issues based on mini-reviews and letters, commentaries, technical notes and drug clinical trial studies on major advances in all areas of drug metabolism and disposition.

The Emerging Sources Citation Index (ESCI), a new database within the Web of Science by Clarivate Analytics, has accepted to index four journals published by Bentham Science Publishers. The titles are:

Current Drug Therapy

The Emerging Sources Citation Index (ESCI) is a new index by Clarivate Analytics, extending the range of publications in Web of Science to include high-quality, peer-reviewed publications of regional importance and in emerging scientific fields. ESCI complements the highly selective indexes by providing earlier visibility for sources under evaluation as part of SCIE, SSCI, and AHCI’s rigorous journal selection process. Inclusion in ESCI provides greater discoverability which leads to increased citations.

Current Organocatalysis published by Bentham Science Publishers, has been accepted for inclusion in Scopus. Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings.

Current Organocatalysis is an international peer-reviewed journal that publishes significant research in all areas of organocatalysis. The journal covers organo homogeneous/heterogeneous catalysis, innovative mechanistic studies and kinetics of organocatalytic processes focusing on practical, theoretical and computational aspects. It also includes potential applications of organocatalysts in the fields of drug discovery, synthesis of novel molecules, synthetic method development, green chemistry and chemoenzymatic reactions.

For more information about the journal, please visit: https://benthamscience.com/journals/current-organocatalysis/

Viewing the present situation in chemistry research, Bentham Science Publishers continues to explore new ideas and concepts. This has been demonstrated by launching several new journals and also expanding the scope of the existing journals. We have been publishing Current Organocatalysis for the past three years. However, we were unable to accept a number of manuscripts since those were not related to organocatalysis, but they were related to synthetic methods. Therefore, we have decided to expand the scope and aim of Current Organocatalysis and give it a new name, Current Organocatalysis and Synthetic Methods starting from January, 2018.

Current Organocatalysis and Synthetic Methods is an international peer-reviewed journal that publishes significant research in all areas of organocatalysis. The journal covers organo homogeneous/heterogeneous catalysis, innovative mechanistic studies and kinetics of organocatalytic processes, focusing on practical, theoretical and computational aspects. It also includes potential applications of organocatalysts in the fields of drug discovery, synthesis of novel molecules, synthetic method development, green chemistry and chemoenzymatic reactions.

This journal also covers new methods, reagents, mechanisms of chemical synthesis. New synthetic methods have become extremely popular for the preparation of simple to structurally complex molecules. For example, in many instances it is necessary to demonstrate the usefulness of the new methods. An effective method produces products with high yield in an economical way. There is an existing challenge to identify appropriate synthetic methods that are diastereoselective, enantioselective, and chemoselective. Synthesis of molecules that have commercial interest due to their medicinal importance and the extraction of natural products by new methods requires careful thinking, design and execution. Development of efficient reagents and conditions are necessary for the retrosynthetic analysis that is dependent on a small part of the desired molecules. Current Organocatalysis and Synthetic Methods accepts papers, reviews, short communications, and perspectives. It is the premier source information related to the fields of of organocatalysis and synthetic methods n for chemists, biologists and engineers pursuing research in industry and academia.

For more information, please visit: https://benthamscience.com/journals/current-organocatalysis/

Editor-in-Chief: Dr. Bimal K. Banik Vice President of Research & Education Development Community Health Systems of South Texas (CHSST) Edinburg, Texas USA

Phone: 281-813-2104, Fax: 956-259-8085; E-mail: bimalbanik10@gmail.com; bimal.banik@chsst.org

The Emerging Sources Citation Index (ESCI) has accepted to index two journals published by Bentham Science Publishers. The titles are: Recent Patents on Inflammation & Allergy Drug Discovery and Recent Patents on Endocrine, Metabolic & Immune Drug Discovery.

The Emerging Sources Citation Index (ESCI) is a new index launched by Thomson Reuters, extending the universe of publications in Web of Science to include high-quality, peer-reviewed publications of regional importance and in emerging scientific fields.

Recent Patents on Inflammation & Allergy Drug Discovery and Recent Patents on Endocrine, Metabolic & Immune Drug Discovery are published by Bentham Science under the banner of 'Patent Review titles'. The journals publish peer-reviewed review and research articles on important recent patents on these topics.

Clarivate Analytics has recently included the following 16 eBooks for coverage in Book Citation Index . The Book Citation Index in Web of Science ™ Core Collection connects a library’s book collection to powerful new discovery tools, giving researchers the ability to quickly and easily identify and access the most relevant books.

The list of the indexed books is below:

To view the entire library of 700+ Bentham eBooks, download our eBook catalog here.

Thomson Reuters has selected the following Journals published by Bentham Science Publishers for coverage in The Emerging Sources Citation Index (ESCI). ESCI is a new index launched by Thomson Reuters, extending the universe of publications in Web of Science to include high-quality, peer-reviewed publications of regional importance and in emerging scientific fields.

The Emerging Sources Citation Index (ESCI) is a new index launched by Thomson Reuters, extending the universe of publications in Web of Science to include high-quality, peer-reviewed publications of regional importance and in emerging scientific fields.

Adolescent Psychiatry publishes original research, critical reviews of topics relevant to practitioners, clinical observations with analysis and discussion, analysis of philosophical, ethical or social aspects of the fields of psychiatry and mental health, case reports with discussions, letters, and position papers.

For more information about the journal, visit: http://benthamscience.com/journals/adolescent-psychiatry/#top

Bentham Science is pleased to announce the launch of a new journal, Current Applied Polymer Science . The inaugural journal issue is available online for free access here: https://benthamscience.com/journals/current-applied-polymer-science/volume/1/issue/1/

Current Applied Polymer Science publishes expert review articles and thematic issues in all applied aspects of polymer science. The founding editor of Current Applied Polymer Science is Dr. Sixun Zheng (Shanghai Jiao Tong University, Shanghai, China). View the full editorial board of the journal here.

For more details please visit the journal website.

Clarivate Analytics (formerly Thomson Reuters Intellectual Property & Science business) has selected the Bentham Science journal Current Molecular Pharmacology for coverage in the Science Citation Index (SCI). The Science Citation Index (SCI) is a citation index originally produced by the Institute for Scientific Information (ISI) and is made available online through different platforms, such as the Web of Science and SciSearch.

Current Molecular Pharmacology publishes the latest developments in cellular and molecular pharmacology with a major emphasis on the mechanism of action of novel drugs under development, innovative pharmacological technologies, cell signaling, transduction pathway analysis, genomics, proteomics, and metabonomics applications to drug action.

For more information about the journal, visit: http://benthamscience.com/journals/current-molecular-pharmacology/

Clarivate Analytics (formerly Thomson Reuters Intellectual Property & Science business) has selected the Bentham Science journal Current Psychiatry Reviews for coverage in The Emerging Sources Citation Index (ESCI). ESCI is a new index, extending the universe of publications in Web of Science to include high-quality, peer-reviewed publications of importance in emerging scientific fields.

Current Psychiatry Reviews publishes frontier review articles and guest edited issues dedicated to clinical research on all the latest advances on clinical psychiatry and its related areas e.g. pharmacology, epidemiology, clinical care and therapy. The journal is essential reading for all clinicians, psychiatrists and researchers in psychiatry.

For more information about the journal, visit: http://benthamscience.com/journals/current-psychiatry-reviews/

Pharmaceutical Nanotechnology, an important journal published by Bentham Science, is accepted to be included in MEDLINE. MEDLINE is the U.S. National Library of Medicine® (NLM) premier bibliographic database that contains more than 23 million references to journal articles in life sciences with a concentration on biomedicine. A distinctive feature of MEDLINE is that the records are indexed with NLM Medical Subject Headings (MeSH®). For more information, view: https://www.nlm.nih.gov/pubs/factsheets/medline.html/

Pharmaceutical Nanotechnology publishes original manuscripts, reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterization and pharmaceutical (or diagnostic) application of materials at the nanoscale.

For more information, please visit: http://benthamscience.com/journals/pharmaceutical-nanotechnology/

Scopus recently released information about the published content hosted by the service. According to the information presented, Bentham Science is among the top 14 publishers which have their publications indexed in Scopus.

Learn more about the breakdown of Scopus content by publishers here: https://www.elsevier.com/solutions/scopus/content

Bentham Science will continue to expand on its product portfolio in line with its mission to facilitate the publication of latest research around the globe. We are also committed to increasing the exposure of researchers who publish their work with us.

About Scopus

Scopus is the largest abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings. Delivering a comprehensive overview of the world's research output in the fields of science, technology, medicine, social sciences, and arts and humanities, Scopus features smart tools to track, analyze and visualize research.

https://www.elsevier.com/solutions/scopus/

About Bentham Science Publishers

Bentham Science Publishers is a major publisher of over 100 peer reviewed journals and 600 eBooks. Some of the notable Bentham Science journals that have received ISI Impact factor (IF) rankings are Current Neuropharmacology (IF 3.75) Current Cancer Drug Targets (IF 3.71), Recent Patents on Anti-Cancer Drug Discovery, (IF 3.53), Current Medicinal Chemistry (IF 3.46) among other titles.

https://www.benthamscience.com/

The article “Impacts of Bioinformatics to Medicinal Chemistry” published in Medicinal Chemistry Volume 11, Issue 3 (2015), was selected as a Hot Paper and Highly Cited Paper by Web of Science, Thomson Reuters.

Medicinal Chemistry, a peer-reviewed journal, aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design. The journal publishes original research, mini-review articles and guest edited thematic issues covering recent research and developments in the field.

To view the article visit: http://benthamscience.com/journals/medicinal-chemistry/volume/11/issue/3/page/218/

Current Respiratory Medicine Reviews published by Bentham Science Publishers has been indexed in Emerging Sources Citation Index (ESCI).

As a new index in the Web of Science™ Core Collection, Emerging Sources Citation Index (ESCI) expands the citation universe and reflects the growing global body of science and scholarly activity. ESCI complements the highly selective indexes by providing earlier visibility for sources under evaluation as part of SCIE, SSCI, and AHCI’s rigorous journal selection process. Inclusion in ESCI provides greater discoverability which leads to measurable citations and more transparency in the selection process.

Current Respiratory Medicine Reviews publishes original research papers, frontier reviews, drug clinical trial studies and guest edited issues dedicated to clinical research on all the latest advances on respiratory diseases and its related areas e.g. pharmacology, pathogenesis, clinical care, therapy. The journal is essential reading for all researchers and clinicians in respiratory medicine.

International Journal of Sensors, Wireless Communications and Control published by Bentham Science Publishers has been accepted for inclusion in Scopus. Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings.

International Journal of Sensors, Wireless Communications and Control publishes timely research articles, reviews and communications on these three strongly related areas, with emphasis on networked control systems whose sensors are interconnected via wireless communication networks.

Book Citation Index has indexed twenty seven books on various subject areas published by Bentham eBooks. The Book Citation Index in the Web of Science, Thomson Reuters, connects a collection of books from a library to powerful new discovery tools, enabling the researchers to quickly and easily identify, and access the most relevant books.

Following is the list of books included in the index:

Current Perspectives in Clinical Treatment & Management in Workers' Compensation Cases

Thomson Reuters has selected the following Journals published by Bentham Science Publishers for coverage in The Emerging Sources Citation Index (ESCI). ESCI is a new index launched by Thomson Reuters, extending the universe of publications in Web of Science to include high-quality, peer-reviewed publications of regional importance and in emerging scientific fields.

Current Radiopharmaceuticals

Journal Homepage: Current Radiopharmaceuticals

Current Traditional Medicine has been indexed by Chemical Abstracts Service, CAS, a division of the American Chemical Society, dedicated to the ACS vision of transforming the power of chemistry.

Current Traditional Medicine covers all the aspects of the modernization and standardization research on traditional medicine of the world, e.g. chemistry, pharmacology, molecular mechanism, systems biology, proteomics, genomics, metabolomics, safety, quality control, clinical studies of traditional Chinese, Ayurvedic, Unani, Arabic and other ethnomedicine.

For details visit: http://benthamscience.com/journals/current-traditional-medicine/#top

Bentham Science Publishers has a new Chinese language website which aims to provide essential information on Bentham Science's publications to Chinese readers and subscribers. The new website has the same visual design as the English website and features translated subscription journal titles and article abstracts. With this partial Chinese language website, Bentham Science aims to increase its presence in the region with its range of publications. To learn more about the new website, please visit the website here:

http://chinese.benthamscience.com/

September 6, 2016: The recent issue of Current Medicinal Chemistry (CMC, Vol. 23; Iss. 24) features a tribute to the Nobel Prize winning chemist, Professor Ferid Murad (George Washington University). Prof. Murad has been recognized in the field of medicinal chemistry for his contributions to our understanding of nitric oxide release in the body through the action of nitroglycerin and related drugs. Prof. Murad’s work pointed out that release of nitric oxide leads to a biochemical cascade that results in high cGMP, resulting in smooth muscle relaxation. He, along with Furchgott and Ignarro, were jointly awarded the Nobel Prize in Physiology & Medicine in 1998 for these discoveries.

This issue brings forth 16 reviews written by eminent experts on the biochemistry of nitric oxide from diverse scholarly angles. Readers will find updated research on topics ranging from cGMP pathways triggered by nitric oxide, the effect of nitric oxide on specific cells to the value of nitric oxide in certain disease states. The editors of CMC thank the contributors to this outstanding collection of excellent reviews and hope that that readers can benefit from the advances in medicinal chemistry triggered by Prof. Murad’s monumental research contributions.

Dubai, UAE, June 23, 2016: Endocrine, Metabolic & Immune Disorders - Drug Targets has obtained its first Impact Factor 1.987. The Impact Factor ranking has been awarded by Journal Citation Reports®, which are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data.

Endocrine, Metabolic & Immune Disorders - Drug Targets publishes timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. For more information, please visit: http://benthamscience.com/journals/endocrine-metabolic-and-immune-disorders-drug-targets/

Dubai, UAE, June 22, 2016: The Bentham Science journal Current Drug Safety has been accepted for inclusion in Emerging Sources Citation Index (ESCI) and will appear in WoS by August 2016.

Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, reviews and case reports in the field. The topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, and post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety. For more information about the journal, please visit here

As a new index in the Web of Science™ Core Collection, Emerging Sources Citation Index (ESCI) expands the citation universe and reflects the growing global body of science and scholarly activity. ESCI complements the highly selective indexes by providing earlier visibility for sources under evaluation as part of SCIE, SSCI, and AHCI’s rigorous journal selection process. Inclusion in ESCI provides greater discoverability which leads to measurable citations and more transparency in the selection process.

For further information on Emerging Sources Citation Index (ESCI), please visit: http://wokinfo.com/products_tools/multidisciplinary/esci/

Dubai, UAE, June 18, 2016: According to the recently released Journal Citation Reports® 2015, 39 Bentham Science Journals have received Impact Factors. Current Neuropharmacology has the highest impact factor from all Bentham Science Journals. These positive results reflect the overall high quality of research published by Bentham Science.

Following are the top 10 high impact factor journals published by Bentham Science:

Current Neuropharmacology

Journal Homepage: Current Neuropharmacology

Impact Factor: 3.753

Journal Citation Reports (JCR) are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data. Bentham Science publishes over 100 print & online scholarly subscription journals; website at http://benthamscience.com/

Bentham Science is pleased to announce the launch of a new journal, Current Nanomaterials . The inaugural journal issue is available online for free access via: http://benthamscience.com/journals/current-nanomaterials/volume/1/issue/1/

Current Nanomaterials is a peer reviewed journal publishes reviews, original research articles and thematic issues on experimental and applied research on nanomaterials. The journal is available in both electronic and print editions.

For more details please visit the journal website: http://benthamscience.com/journals/current-nanomaterials/#top

Authors: Nakamura, Masanori; Ujihara, Yoshihiro

Source: Micro and Nanosystems, Volume 7, Number 3, August 2015, pp. 135-141(7)

A group of researchers from Japan has examined how the hold position of a red blood cell affects its mechanical characteristics in tensile tests.

The tensile test is the most fundamental type of mechanical test in material science to understand mechanical properties of material of interest. Although the tensile test has also been used in cellular mechanics, large variations were found in experimental data unlike metallic materials. Conventionally, the variations were attributed to sample-to-sample variations as is common in biological studies. Yet the researchers, who have been engaged in tensile tests of cells for many years, experienced difficulties in controlling the hold position of cells under a microscope using a needle and a micropipette, and hypothesized that differences in the hold position yielded the experimental errors.

The researchers reproduced the tensile test of a red blood cell in silico using a particle method that describes the motion of fluid and the structure as the collective behavior of particles. This method allows a fluid-structure interaction analysis with ease compared to other numerical methods such as finite element methods.

The results show significant varitions in the deformed geometry of the red blood cell during the tensile test, as well as variations in strain distribution. Of the hold patterns examined, with an applied strain of 0.8, the misaligned stretch increased the maximum of the first principal strain by 65–85% in comparison to the aligned stretch.

Although it would be ideal to precisely align the hold position with the stretch to gain correct data, this represents a significant practical challenge. A take-home message of this study is that, for the interpretationof RBC tensile test results, we should always bear in mind that tensile test data are significantly affected by the hold position.

Authors: Shaji, Jessy; Menon, Ipshita

Source: Drug Delivery Letters, Volume 5, Number 3, December 2015, pp. 188-200(13)

The objective of our study was to exploit the principles of quality by design (QbD) to assist the formulation development. QbD helped identify the variables causing potential risk to the quality attributes namely, particle size and entrapment efficiency. The factors causing high risk to the quality attributes were further studied using an experimental design in order to improve the product quality. The application of QbD aided the development of stable formulations of enhanced quality. The optimized PEGylated mixed micelles of meloxicam (M-PMM) had a high percent entrapment efficiency of 73.6% ± 0.72% and mean particle size of 132 nm ± 67nm. The cytotoxicity of M-PMM was much higher (GI 50 <10µg/mL) than free meloxicam (MLX) and conventional mixed micelles (GI 50 >80µg/mL). This was achieved essentially due to the presence of PEG corona which enhanced the cellular association with the HT-29 cell lines. The PEG corona also enhanced the stability of the mixed micelles formulation as observed in the zeta potential data. The M-PMM had a zeta potential of -31mv. It was observed that M-PMM was capable of releasing MLX in a slow and sustained manner; releasing 62.7% ± 0.37% drug in 24h. The formation of ellipsoidal mixed micelles was confirmed by small angle neutron scattering (SANS) analysis. The shape and size of the M-PMM was further corroborated by transmission electron microscopy (TEM). The differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FT-IR) and powder X-ray diffraction (PXRD) results justified that MLX was entrapped inside the PEGylated mixed micelles and was stabilized in the amorphous form. A long term stability study indicated that the formulation was stable for three months. As a result, it was concluded that PEGylated mixed micelles can be considered to be a promising system for the delivery of MLX. Furthermore, the in vitro cytotoxicity results affirmed that M-PMM could serve as a better alternative for treating and preventing human colorectal cancer.

Dubai, UAE: Thomson Reuters has selected the following Journals published by Bentham Science Publishers for coverage in The Emerging Sources Citation Index (ESCI). ESCI is a new index launched by Thomson Reuters, extending the universe of publications in Web of Science to include high-quality, peer-reviewed publications of regional importance and in emerging scientific fields.

Current Diabetes Reviews

Journal Homepage: http://benthamscience.com/journals/current-diabetes-reviews/

Source: Current Analytical Chemistry, Volume 11, Number 4, October 2015, pp. 279-290(12)

Publisher: Bentham Science Publishers

Hassan H. Hammud^*1, Mohammad H. El-Dakdouki², Nada Sonji², Ghassan Sonji² and Kamal H. Bouhadir³

¹Department of Chemistry, Faculty of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia;

²Department of Chemistry, Faculty of Science, Beirut Arab University, Debbieh, Lebanon;

³Department of Chemistry, Faculty of Arts and Sciences, American University of Beirut, Beirut,Lebanon

E-mail: hhammoud@kfu.edu.sa

Water quality surveillance is given maximum priority, for safety assessment of the environment and human health in particular. Among the inorganic contaminants of water, heavy metals are getting much attention because of their non-biodegradable nature and permanent accumulation in living tissues causing lethal biological disorders. Consequently, there is a growing urgency for the development of simple, quick, versatile, and reliable methods for control recognition of metal ions at very low concentrations. In this context, N-[[(6-Amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)amino]thioxomethyl]- benzamide, a novel diaminouracilbenzoylthiourea (DAUTU)-based fluorescent probe was synthesized in high yield via a single-step facile reaction, and characterized by various spectral techniques. The chemically stable probe exhibited strong fluorescent emission at 385 nm upon excitation at 362 nm. The probe has been successfully deployed for the selective detection and accurate determination of trace amountsof Ag⁺, Cu²⁺ and Fe³⁺ ions in aqueous samples spiked with competing metal ions, as well as in natural water samples thus demonstrating its versatile applicability. The detection was pH-independent, and detection limits ranged from 0.0716-0.286 μM for the analyzed cations which is sufficiently well below the safety levels set by U.S. EPA. Importantly, detection was achieved in short response times with high accuracy, reproducibility, sensitivity, and reversibility.

The sensing principle is based on remarkable fluorescence quenching in presence of the detected metal ions via excitation energy transfer from the probe to the d-orbital in the atoms of the metals. In summary, we developed an efficient, cost effective, and easily operated uracil-based chemosensor for the rapid detection and sensitive determination of Ag⁺, Cu²⁺ and Fe³⁺ ion concentrations in diverse real world applications.

Authors: Aggarwal, Shilpa; Dodd, Seetal; Berk, Michael

Source: Current Drug Safety, Volume 10, Number 2, July 2015, pp. 98-105(8)

Publisher: Bentham Science Publishers

Thereview article deals with Restless Leg Syndrome (RLS) associated with Atypical Antipsychotics (AAP). RLS, although a common disorder, is frequently of unclear origin. It is often associated with significant distress and when related to medications, can interfere with the compliance. It reduces the psychosocial quality of life, which is comparable to that of patients having type-2 diabetes mellitus, and osteoarthritis.

In this research, Dr. Shilpa and her colleagues review the evidence for AAP causing RLS. There is limited information available in this area comprising only a few case reports and case series. It is possible that such movements are not being recognised or sought for by the clinicians, as it is not a widely known or reported side effect. After elaborating on and discussing the available case reports and case series, the paper goes on to discuss the implicated pathophysiological mechanisms of RLS associated with AAP. A discussion about the central dopaminergic dysfunction, neuroimaging findings, genetic influences, and brain iron deficiency is included in the paper.

The researchers have shed light on the clinical implications of RLS associated with AAP andalso the measures to address it. Greater awareness of the potential causes of RLS, and its differentiation from akathisia and illness related agitation might help in reducing the distress associated with it and improve compliance in patients using atypical antipsychotic agents.

Authors: Katsi, Vasiliki; Ioannis, Zerdes; Stavroula, Manolakou; Thomas, Makris; Petros, Nihoyannopoulos; Dimitris, Tousoulis; Ioannis, Kallikazaros

Source: Recent Patents on Cardiovascular Drug Discovery, Volume 9, Number 2, December 2014, pp. 63-72(10)

The introduction of targeted therapies has revolutionized the management of cancer patients. Agents that target the vascular endothelial growth factor (VEGF), called anti-VEGF, have been administrated for the treatment of various cancer types, inhibiting the carcinogenetic procedure of angiogenesis.

Though their beneficial impact on cancer patients’ outcome, anti-VEGF drugs are accompanied with a broad spectrum of side effects. After searching the literature, we focused on the association between mainly used anti-VEGF anticancer drugs and hypertension (HTN).

Many factors are involved in the emergence of HTN in these patients such as reduced levels of nitric oxide (NO) and/or microvascular rarefaction. The incidence of HTN is high and dependent on which agent is used for treating cancer patients.

In two large meta-analyses, bevacizumab-treated patients had an incidence of developing HTN up to 24% while patients with renal cell carcinoma and gastrointestinal stromal tumors treated with sunitinib had a HTN incidence of approximately 22%. Antihypertensive therapies (i.e angiotensin-converting enzyme inhibitors, b-blockers or diuretics) have been used for the management of anti-VEGF-induced HTN.

Interestingly, the onset of HTN can be considered as a possible biomarker of clinical response to VEGF inhibition (VEGFi) treatment, seeming to be correlated with better overall survival (OS) and prolonged progression free survival in these patients.

Close monitoring of blood pressure (BP) levels, early BP control, proper therapeutic interventions are crucial points in the management of HTN caused by VEGFi. In severe hypertensive cases, discontinuation of anti-VEGF agents or switching to another treatment option might be required. Further research is needed for this exact entity to be elucidated and proper algorithms for HTN handling should be proposed for the optimal benefit of cancer patients.

Dubai, UAE: Thomson Reuters has recently included the following 7 eBooks published by Bentham Science for coverage in Web of Science.

Awake Thoracic Surgery

Dubai, UAE: Thomson Reuters has recently included the following 9 eBooks for coverage in Book Citation Index.

Frontiers in Anti-Cancer Drug Discovery, Vol 1

Dubai, UAE: February 01, 2016: Five new podcasts have been uploaded on Bentham Science YouTube Channel. You can watch the podcasts by clicking on the links below:

eBook: Information for Mental Health Providers working with Children who have chronic Illnesses by Dr. Laura Nabors: https://www.youtube.com/watch?v=v_hF2t2E3Ak

For more exclusive podcasts by our authors on journal articles and eBooks, please subscribe to our YouTube channel: http://www.youtube.com/c/BenthamSciencePublishers

Dubai, UAE: Following are the 8 eBooks that are now indexed for coverage in Web of Science.

Prenatal Alcohol Use and Fetal Alcohol Spectrum Disorders: Diagnosis, Assessment and New Directions in Research and Multimodal Treatment

Dubai, UAE: December 23, 2015: Bentham eBooks announces its yearly HOLIDAY SALE 2015-16 starting from 25 Dec’15 till 15 Jan’16. All printed books/eBooks ordered or purchased during this period will be discounted for 10%.

Bulk discount offer: You can Save 15% on buying 15 eBooks and 30% on buying 25 or more eBooks

All printed books will be discounted for 15%. In addition, anyone buying a printed book during the period that this discount is available will receive a free personal electronic version of the book.

Bentham Authors/Editors can save 35% on buying 10 or more printed copies for their libraries or friends.

Readers can choose any book from our catalog of over 500 publications in a variety of scientific fields from our catalogue list here.

For more information on this offer or to place your order, contact our eBooks sales office at ebooks@benthamscience.ae.

Dubai, UAE: December 09, 2015: Five new podcasts have been uploaded on Bentham Science YouTube Channel. You can watch the podcasts by clicking on the links below:

For more exclusive podcasts by our authors on journal articles and eBooks, please subscribe to our YouTube channel: http://www.youtube.com/c/BenthamSciencePublishers

Dubai, UAE: Bentham Science Publishers has signed a collaboration with Kudos to increase the portfolio of its services for Bentham authors.

Kudos is one of the most popular media, used by researchers, to network and highlight their research. It is a web-based service that helps researchers, their institutions and funding agencies to maximize the visibility and impact of their published articles. It aims to provide a highly automated, scalable service to help researchers and their institutions measure, monitor and maximize the usage of and citations to their published articles.

“Kudos gives publishers greater visibility of how their authors are using communications channels including social media, email, academic networks and the wider web,” says Charlie Rapple, Kudos Sales & Marketing Director and Co-Founder. "We are delighted to welcome Bentham Science Publishers to our community, and hope that we can help them to gain insight into how best to spread the word about research publications."

For more information please visit: https://www.growkudos.com/

Dubai, UAE, November 19, 2015: Two new podcasts have been uploaded on Bentham Science YouTube Channel. You can watch the podcasts by clicking on the links below:

For more exclusive podcasts by our authors on journal articles and eBooks, please subscribe to our YouTube channel http://www.youtube.com/c/BenthamSciencePublishers

Dubai, UAE September 28, 2015: Following journal issues have abstracts available in the Chinese language, in addition to English:

Dubai, UAE, September 11, 2015: Three new podcasts produced by Dr. Robert Smith, Dr. Ian Martins and Dr. Christo Boyadjiev based on their articles respectively have been uploaded on Bentham Science YouTube Channel.

Please watch the podcasts by clicking on the links below:

Dubai, UAE August 28, 2015: Bentham Science is pleased to announce that the following journals have abstracts available in the Chinese language, in addition to English:

Dubai, UAE, August 6, 2015: Two new podcasts produced by Dr. Marazziti and Dr. Barrett The Role of Oxytocin in Neuropsychiatric Disorders by Dr. Donatella Marazziti and Ride or Die; Therapeutic Interventions for Retaliatory Violence Among Youth respectively, have been uploaded on Bentham Science YouTube Channel.

These podcasts are based on their articles. Please watch the podcasts by clicking on the links below:

https://www.youtube.com/watch?v=ZR4NjNlVTd4

https://www.youtube.com/watch?v=bKV2dmXBoYw

Bentham Science is pleased to announce the launch of a new journal Current Bionanotechnology. The inaugural journal issue is freely accessible here.

Current Bionanotechnology is an international, peer-reviewed journal for bionanoscience and technology. It covers basic research in biological nanosciences, including in silico work as well as applied research toward the development of new devices and technologies for applications in various industrial fields.

Access the journal here: http://www.benthamscience.com/journals/current-bionanotechnology/#top

Dubai, UAE, 28th July 2015: A brand new podcast produced by Dr. Zhang based on his article: ‘A Survey and a Molecular Dynamics Study on the (Central) Hydrophobic Region of Prion Proteins’ from the journal Current Pharmaceutical Biotechnology has been uploaded on Bentham Science YouTube Channel.

Watch the podcast here: https://youtu.be/ikL0gh7jYJM

Elsevier Broadens Availability of Bentham eBooks in the fields of Medicinal Chemistry & Pharmaceutical Science

Elsevier and Bentham Science recently agreed to a distribution and co-publishing alliance, and the first titles are now available. It’s a mutually beneficial alliance. For Bentham, their chemistry titles will be distributed through Elsevier’s global sales channels, including ScienceDirect, which gives the books higher profile and growth opportunity in the global market. Elsevier benefits with immediate growth in its chemistry portfolio of books, giving researchers greater access to needed chemistry content covering pharmaceutical science, medicinal chemistry, and other multi-disciplinary topics.

The three titles recently published by and available through Elsevier are:

Anti-Angiogenesis Drug Discovery and Development, Volume 2, edited by Atta ur-Rahman and Muhammad Iqbal Choudhary. It covers recent developments reviewed by leading experts in cancer and cardiovascular medicinal chemistry.

Primary editor Atta ur-Rahman,PhD, FRS, FPAS, is a Pakistani organic chemist and a leading scientist in the field of natural product chemistry, with approximately 983 publications to his name in the field of organic chemistry. He has edited more than 40 books published by Bentham Science and Elsevier.

Dubai, UAE, 02 July 2015: Bentham Science journal Current Neuropharmacology has been accepted to be indexed in MEDLINE.

Current Neuropharmacology aims to provide current, timely and comprehensive reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.

MEDLINE citations are indexed with NLM Medical Subject Headings (MeSH®) and are directly searchable from NLM as a subset of PubMed® database.MEDLINE® Medical Literature Analysis and Retrieval System Online is the U.S. National Library of Medicine's ® (NLM) premier bibliographic database that covers areas of the life sciences, behavioral sciences, chemical sciences, and bioengineering. These are mostly scholarly journals, newspapers, magazines, and newsletters considered useful in the field of life sciences.

For further information on Medline, please visit http://www.nlm.nih.gov/pubs/factsheets/medline.html

Dubai, UAE, June 23, 2015: According to the recently released Journal Citation Reports® 2014, 39 Bentham Science Journals have received Impact Factors. Recent Patents On Anti-Cancer Research has the highest impact factor from all Bentham Science Journals. These positive results reflect the overall high quality of research published by Bentham Science.

Following are the top 10 high impact factor journals published by Bentham Science:

Journal Citation Reports (JCR) are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data. Bentham Science publishes over 100 print & online scholarly subscription journals; website at http://benthamscience.com/

Bentham Science is pleased to announce the launch of a new journal ‘Current Traditional Medicine’. The inaugural journal issue is available online for free access via: http://www.benthamscience.com/journals/current-traditional-medicine/#top

Current Traditional Medicine is a leading and important international peer-reviewed journal on current scientific research in global traditional medicine e.g. Chinese, Ayurvedic, and other indiginous ethnic traditional medicine. The journal aims to cover all aspects on modern scientific research of traditional medicine.

For more details, please visit the journal website: http://www.benthamscience.com/journals/current-traditional-medicine/#top

Bentham Science is pleased to announce the launch of a new journal ‘Epigenetic Diagnosis & Therapy.’ The inaugural journal issue is freely accessible here.

For more details, please visit the journal website: http://www.benthamscience.com/journals/epigenetic-diagnosis-and-therapy/#top

Dubai, UAE 5^th May 2015: Chemical Abstracts Service, a division of the American Chemical Society accepts to index two new journals Current Environmental Engineering and Clinical Immunology, Endocrine & Metabolic Drugs published by Bentham Science Publishers.

Chemical Abstracts Service (CAS) aims to deliver comprehensive and useful digital information environment for scientific research and discovery.

Current Environmental Engineering is a peer-reviewed journal that publishes expert reviews, research articles and topical issues on all the major advances in environmental engineering.

For details, please visit the journal website at: http://www.benthamscience.com/journals/current-environmental-engineering/#top

Clinical Immunology, Endocrine & Metabolic Drugs publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical immunology, endocrine & metabolic drug research.

For details, please visit the journal website at: http://www.benthamscience.com/journals/clinical-immunology-endocrine-and-metabolic-drugs/#top

Dubai, UAE, April, 7^th 2015: A new podcast by Dr. Eliade Stefanescu based on the article : “Conversion of Environmental Heat into Usable Energy” from the eBook Open Quantum Physics and Environmental Heat Conversion into Usable Energy has been uploaded on Bentham Science YouTube Channel.

Watch the podcast here: https://youtu.be/0knFrKysiIE

Dubai, UAE, February, 25^th 2015: EMBASE accepts coverage of 33 journal and eBook titles published by Bentham Science Publishers.

EMBASE is a biomedical and pharmacological database containing bibliographic records with citations, abstracts and indexing derived from biomedical articles in peer reviewed journals, and is especially strong in its coverage of drug and pharmaceutical research.

Bentham Science Publishers publishes over 100 print & online scholarly journals and more than 300 eBooks in science, technology, and medicine.

Dubai, UAE, February, 25^th 2015: A new podcast by Dr. Sandeep Patankar based on the article : ‘Plant Glycosides and Aglycones Displaying Antiproliferative and Antitumour Activities – A Review’ from the journal Current Bioactive Compounds 2013, Volume 9, Issue 4, has been uploaded on Bentham Science YouTube Channel.

Watch the podcast here: https://youtu.be/tu-J1pPcUWw

Dubai, UAE, January, 29^th 2015: A new podcast by Dr. Suneela S. Dhaneshwar based on the article ‘Design and Development of Novel Azo Prodrugs using Various Permutations and Combinations of 5- and 4-Aminosalicylic Acids for Inflammatory Bowel Disease: A Colon-Targeted Approach’ from the journal Inflammation & Allergy - Drug Targets, Volume 12, issue 5, has been uploaded on Bentham Science YouTube Channel.

YouTube link: http://youtu.be/TI-aMS3NQE0

Dubai, UAE, December 18th 2014: A new podcast by Dr. Roozbeh Abedini-Nassab, based on his article “Recent Patents and Advances on Applications of Magnetic Nanoparticles and Thin Films in Cell Manipulation” from the journal Recent Patents on Nanotechnology, Volume 8, 3 Issues, 2014, has been uploaded on Bentham Science YouTube Channel.

YouTube link: https://www.youtube.com/watch?v=MfzaZIhktio

Dubai, UAE, Bentham Science Publishers has signed a Chest agreement with EDUSERV for licensing their ejournals and eBooks for universities, colleges, research and charities in the UK and in the Republic of Ireland.

Bentham Science Publishers http://www.benthamscience.com publishes over 100 print & online scholarly journals and more than 300 eBooks in science, technology, and medicine.

Dubai, UAE December 9, 2014: SciVerse Scopus accepts coverage of 241 eBooks published by Bentham Science Publishers. The list of Bentham eBooks recently indexed by Scopus can be viewed at http://benthamscience.com/News/scopus-ebooks.xlsx

Scopus is the largest abstract and citation databases of peer-reviewed literature and quality web sources with smart tools to track, analyze and visualize research.

Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Bentham eBooks are also available in PDF, ePub and Kindle formats that can be ordered directly from the following website: http://benthambooks.com/. Readers can also avail print editions by ordering print-on-demand book copies.

Bentham Science Publishers has made an agreement with China National Publications Import & Export (Group) Corporation (CNPIEC) for a PAY PER VIEW service through CNPIEC’s online service called CNPeReading.

China National Publications Import & Export (Group) Corporation (CNPIEC) is specialized in trading books, periodicals and audio & video products in China.

Bentham Science Publishers is rendering a vital service in the quality publication that publishes over 100 peer-reviewed print and online scientific and medical journals.

Bentham Science Publishers is pleased to announce the launch of a number of journals on the ScholarOne Manuscript site. Through this new electronic dashboard manuscripts can be conveniently submitted, reviewed and their status checked.

Access the below mentioned links for submission:

We are pleased to announce that Bentham Science Publishers will be preserving its e-journals with Portico, ensuring that their content will be secure and available into the future. Bentham Science Publishers is based in Sharjah, United Arab Emirates. [BSP102014]

Bentham Science Publishers is a publishing company of scientific, technical, and medical literature based at Sharjah. Bentham publishes more than 130 subscription-based academic journals across fields of science, technology, and medicine.

In order to facilitate collaboration among researchers, and the dissemination of their scientific research worldwide, Bentham Science Publishers is pleased to announce the publication of a limited number* of Open Access articles in new subscription-based journals at no charge to authors.

*30% of all articles in each issue will be deemed Open Access upon the sole discretion of the journal’s Editor-in-Chief.

The following journals and their volumes are included in this initiative:

Bussum, Netherlands, 18 September 2014: Chemical Abstracts Service, a division of the American Chemical Society accepts to index two new journals Current Microwave Chemistry and Current Organocatalysis published by Bentham Science Publishers.

Current Microwave Chemistry is an international peer-reviewed journal that publishes important contributions describing advances in the use of the microwave across the field of in chemistry, biology, medicine, biomedical science, and engineering.

For details, please visit the journal website at: http://www.benthamscience.com/journals/current-microwave-chemistry/aims-scope/

Current Organocatalysis is an international peer-reviewed journal that publishes significant research in all areas of organocatalysis. The journal covers organo homogeneous/heterogeneous catalysis, innovative mechanistic studies and kinetics of organocatalysis processes focusing on practical, theoretical and computational aspects.

For details, please visit the journal website at: http://www.benthamscience.com/journals/current-organocatalysis/#top

Bentham Science has made an agreement with Society of Physician Entrepreneurs (SOPE) for the journal Technology Transfer and Entrepreneurship that offers a discounted subscription rate (Print & Online) to the members of SOPE.

Society of Physician Entrepreneurs (SOPE) is a global biomedical and healthcare innovation network with the vision to create a global community that accelerates medical innovation to patients around the globe. For more details please visit website: http://www.sopenet.org/

Technology Transfer and Entrepreneurship (TTE) publishes definitive review articles including case histories covering a broad range of topics that underlie the business of biomedical and research, specifically translating basic scientific discoveries into commercial opportunities. This includes understanding of the technology transfer process and entrepreneurship in academia, the biotechnology and pharmaceutical industries; directed towards economic development, better healthcare, and long-term job creation.

For more details please visit the journal website: http://www.benthamscience.com/journals/technology-transfer-and-entrepreneurship/#top

Bussum Netherlands, August 28, 2014: A Podcast by Dr. Dr. Luciana Vasques, based on his article “MicroRNAs: Modulators of Cell Identity, and their Applications in Tissue Engineering”, published MicroRNA, (miRNA) Volume 3, 1 Issues, 2014, has been recently shared on Bentham Science's YouTube Channel at: https://www.youtube.com/watch?v=uEw2c_qyXT4&list=UUFzSVHgGkjFW2Q8WV8-gzUw

Bentham Science is pleased to announce the launch of a new journal, Clinical Immunology, Endocrine & Metabolic Drugs. The inaugural journal issue is available online for free access via: Clinical Immunology, Endocrine & Metabolic Drugs

Clinical Immunology, Endocrine & Metabolic Drugs publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical immunology, endocrine & metabolic drug research. The journal is available in both electronic and print editions.

For more details please visit the journal website Clinical Immunology, Endocrine & Metabolic Drugs

Bussum Netherlands, August 12, 2014: A Podcast by Dr. Vikas Telvekar, based on his article “Synthesis and Biological Evaluation of Novel N' (4 -aryloxybenzylidene) -1H- Benzimidazole- 2 Carbohydrazide Derivatives as Anti - Tubercular Agents”, published in Combinatorial Chemistry & High Throughput Screening Vol. 17, No. 10, has been recently shared on Bentham Science's YouTube Channel at http://www.youtube.com/watch?v=cS05uRRcuEc&feature=youtu.be

Another Podcast by Yusuf Tutar, based on his article “Heat Shock Protein 90 Inhibitors in Oncology”, published in Current Proteomics Vol. 11, No. 4, has been recently shared on Bentham Science's YouTube Channel at https://www.youtube.com/watch?v=0JcKKAyjyQQ&list=UUFzSVHgGkjFW2Q8WV8-gzUww

Bussum, Netherlands, August 7, 2014: According to the recently released Journal Citation Reports® 2013, 39 Bentham Science Journals have received Impact Factors. The journal Current Drug Delivery has its first Impact factor at 2.248. These positive results reflect the overall high quality of research published by Bentham Science.

A selection of top journals published by Bentham Science include:

Journal Citation Reports (JCR) are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data.

Bentham Science publishes over 100 print & online scholarly subscription journals; website at www.benthamscience.com

Bussum Netherlands, August 7, 2014: A Podcast by Dr. Jianhua Xiong, based on his article “Key Roles of MicroRNA-22 Family in Complex Organisms Inferred from its Evolution”, published MicroRNA, (miRNA) Volume 3, 3 Issues, 2014, has been recently shared on Bentham Science's YouTube Channel at: https://www.youtube.com/watch?v=XlVgS-yxAQk&feature=youtu.be

Bussum, Netherlands, 17 July 2014: Chemical Abstracts Service, a division of the American Chemical Society accepts to index three new journals Clinical Anti-Inflammatory & Anti-Allergy Drugs, and Current Microwave Chemistry and Current Organocatalysis published by Bentham Science Publishers.

Chemical Abstracts Service (CAS) aims to deliver comprehensive and useful digital information environment for scientific research and discovery.

Clinical Anti-Inflammatory & Anti-Allergy Drugs publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical anti-inflammatory & anti-allergy drug research. For details, please visit the journal website at: Clinical Anti-Inflammatory & Anti-Allergy Drugs.

Current Microwave Chemistry is an international peer-reviewed journal that publishes important contributions describing advances in the use of the microwave across the field of in chemistry, biology, medicine, biomedical science, and engineering. For details, please visit the journal website at: Current Microwave Chemistry.

Current Organocatalysis is an international peer-reviewed journal that publishes significant research in all areas of organocatalysis. For details, please visit the journal website at: Current Organocatalysis.

Bussum, Netherlands, 04 July 2014: Bentham Science is delighted to announce that Current Pediatric Review and MicroRNA has been accepted for indexing in MEDLINE®.

Current Pediatric Reviews publishes frontier reviews, drug clinical trial studies and guest edited thematic issues on all the latest advances in pediatric medicine. The journal’s aim is to publish the highest quality review articles dedicated to clinical research in the field. For details, please visit the journal website at Current Pediatric Reviews

MicroRNA publishes loriginal research and review articles, drug clinical trial studies and thematic issues on all aspects of microRNA (miRNA) research. The scope of the journal covers all experimental miRNA research and applied research in health and disease, including therapeutic, biomarker, and diagnostic applications of MiRNA. For details, please visit the journal website at MicroRNA.

MEDLINE^® Medical Literature Analysis and Retrieval System Online is the U.S. National Library of Medicine's ^® (NLM) premier bibliographic database that covers areas of the life sciences, behavioral sciences, chemical sciences, and bioengineering. MEDLINE also covers aspects of biology, environmental science, marine biology, plant and animal science as well as biophysics and chemistry. MEDLINE is the primary component of PubMed^®, part of the Entrez series of databases provided by NLM's National Center for Biotechnology Information (NCBI). Publications covered in MEDLINE are mostly scholarly journals, newspapers, magazines, and newsletters considered useful in the field of life sciences. For further information about Medline visit http://www.nlm.nih.gov/pubs/factsheets/medline.html

Nobel Prize Winners, Professor Jean-Marie Lehn and Professor Ferid Murad have joined as Honorary Senior Advisors to the Editorial Board of the journal, Current Medicinal Chemistry.

Professor Jean-Marie Lehn from France received a Nobel Prize in Chemistry in 1987 for his work on synthesis of cryptands. Prof. Lehn was an early innovator in the field of supramolecular chemistry. His group has published in excess of 900 peer-reviewed research articles.

Professor Ferid Murad from USA received a Nobel Prize in 1998 in the discipline of Physiology or Medicine for discoveries concerning nitric oxide as a signaling molecule in the cardiovascular system. He is currently affiliated with George Washington University.

About Current Medicinal Chemistry

Current Medicinal Chemistry (Impact Factor 4.07) covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal has already scored an impact factor of 4.02 as per journal citation report 2012. For more info click here

Bentham Science is pleased to announce the launch of a new journal, Current Organocatalysis. The inaugural journal issue is available online for free access via: http://www.benthamscience.com/journals/current-organocatalysis/volume/1/issue/1/

Current Organocatalysis is an international peer-reviewed journal that publishes significant research in all areas of organocatalysis. The journal is available in both electronic and print editions.

For more details please visit the journal website: http://www.benthamscience.com/journals/current-organocatalysis/#top

Bentham Science is pleased to announce the launch of a new journal, Current Environmental Engineering. The inaugural journal issue is available online for free access via: http://www.benthamscience.com/journals/current-environmental-engineering/volume/1/issue/1/

Current Environmental Engineering is a peer-reviewed journal that publishes expert reviews, research articles and topical issues on all the major advances in environmental engineering.The journal is available in both electronic and print editions.

For more details please visit the journal website: http://www.benthamscience.com/journals/current-environmental-engineering/#top

Bussum, Netherlands, 27 May 2014: Bentham Science Publishers is pleased to announce the launch of a new journal, Current Microwave Chemistry in May 2014. The inaugural journal issue is available online for free access via: http://www.benthamscience.com/journals/current-microwave-chemistry/volume/1/issue/1/

The journal covers microwave-assisted synthesis of novel organic, organometallic and inorganic molecules or complexes, kinetics and mechanistic studies of microwave-induced chemical reactions and potential use of microwave irradiation in the fields of drug discovery, green chemistry, catalysis and industrial process development. The journal is available in both electronic and print editions.

For more details on this new journal, visit the website: Current Microwave Chemistry

Bentham Science is proud to announce the launch of a new journal, Applied Clinical Research, Clinical Trials and Regulatory Affairs in April 2014. The inaugural journal issue is available online for free access via: http://www.benthamscience.com/journals/applied-clinical-research-clinical-trials-and-regulatory-affairs/volume/1/issue/1/

The journal publishes innovative, developmental and original research on validated experimental design, methods, representation and interpretation of clinical research and drug trials. Additionally, the journal publishes original research articles, reviews, short communications and thematic journal issues. Published work is based on solid clinical, scientific and statistically relevant results that lead to advancements in clinical medicine, clinical research, regulatory affairs and human subject protection in the areas of biological advances, drugs, bio-therapeutics and devices. The journal is available in both electronic and print versions.

For more details on this new journal, please visit the website: Applied Clinical Research, Clinical Trials and Regulatory Affairs

Bentham Science Publishers is proud to announce the launch of a new journal, Technology Transfer and Entrepreneurship in April 2014. The inaugural journal issue is available online for free access via: http://www.benthamscience.com/journals/technology-transfer-and-entrepreneurship/volume/1/issue/1/

Technology Transfer and Entrepreneurship publishes definite review articles including case histories covering a broad range of topics that underline the business of biomedical and research, specifically translating basic scientific discoveries into commercial opportunities. The journal is available in both electronic and print editions.

For more details on this new journal, visit the website: Technology Transfer and Entrepreneurship.

Bussum Netherlands, April 14, 2014: A Podcast by Dr. Daniela Marasco, based on his article “From Peptides to Small Molecules: An Intriguing but Intricated Way to New Drugs”, published in Current Medicinal Chemistry Vol. 20, No. 31, has been recently shared on Bentham Science's YouTube Channel at: https://www.youtube.com/watch?v=BDQMgIYmGog

Bussum, Netherlands, April 1, 2014: A podcast by Dr. Oriana Tabarrini, based on his article “From Small to Powerful: The Fragments Universe and its Chem-Appeal”, published in Current Medicinal Chemistry Vol.20, No. 11, 2013 has been recently shared on Bentham Science's YouTube channel at https://www.youtube.com/watch?v=-PkU2EUDmX4&feature=youtu.be

For further details, please visit : Current Medicinal Chemistry.

Bussum, Netherlands, 31 March 2014: Bentham Science is pleased to announce the launch of a new journal, Clinical Anti-Inflammatory & Anti-Allergy Drugs. This journal is published in both print and electronic editions. The inaugural journal issue is available for free viewing online via Clinical Anti-Inflammatory & Anti-Allergy Drugs .

Clinical Anti-Inflammatory & Anti-Allergy Drugs, an international peer-review journal, publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical anti-inflammatory & anti-allergy drug research.

Bussum, Netherlands, 20 March 2014: Chemical Abstracts Service, a division of the American Chemical Society accepts to index two new journals Current Chromatography and Clinical Cancer Drugs published by Bentham Science Publishers.

Chemical Abstracts Service (CAS) aims to deliver comprehensive and useful digital information environment for scientific research and discovery.

Current Chromatography is an international peer-reviewed journal, which publishes expert reviews, original research articles and thematic issues in all core areas of separation science. For details, please visit the journal website at: Current Chromatography.

Clinical Cancer Drugs publishes original research , expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research. For details, please visit the journal website at: Clinical Cancer Drugs.

Bussum, Netherlands, 12 March 2014: MEDLINE^® accepts coverage of the journal Current Rheumatology Reviews published by Bentham Science Publishers.

Current Rheumatology Reviews publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances on rheumatology and its related areas e.g. pharmacology, pathogenesis, epidemiology, clinical care and therapy. For details, please visit the journal website at Current Rheumatology Reviews.

MEDLINE^® Medical Literature Analysis and Retrieval System Online is the U.S. National Library of Medicine's^® (NLM) premier bibliographic database that covers areas of the life sciences, behavioral sciences, chemical sciences, and bioengineering. MEDLINE also covers aspects of biology, environmental science, marine biology, plant and animal science as well as biophysics and chemistry. MEDLINE is the primary component of PubMed^®, part of the Entrez series of databases provided by NLM's National Center for Biotechnology Information (NCBI). Publications covered in MEDLINE are mostly scholarly journals, newspapers, magazines, and newsletters considered useful in the field of life sciences. For further information about Medline visit www.nlm.nih.gov/pubs/factsheets/medline.html.

Bussum, Netherlands, 11 March 2014: Chemical Abstracts Service, a division of the American Chemical Society accepts to index a new journal Current Biochemical Engineering. published by Bentham Science Publishers.

Chemical Abstracts Service (CAS) aims to deliver comprehensive and useful digital information environment for scientific research and discovery. It provides pathways to publish research in the world’s journal and patent literature relevant to life science, chemistry and other scientific fields.

Current Biochemical Engineering, is an international peer-reviewed journal, that publishes expert review and guest edited issues on all major advances in biochemical engineering.

Bentham Science Publishers is proud to announce the launch of a new journal, Current Chromatography in January 2014. This latest journal is available in both electronic and print versions. The inaugural journal issue is available online for free via Current Chromatography.

Current Chromatography aims to publish major advances in both basic and applied separation science of relevance to chemical and biomedical disciplines.

For more details on this new journal, log on to the website: Current Chromatography.

Chemical Abstracts Service, a division of the American Chemical Society accepts to index in CAS a new journal Current Green Chemistry published by Bentham Science Publishers.

Current Green Chemistry is an international peer-reviewed journal that publishes original research, expert reviews and thematic issues in all major areas of green chemistry. For further details and FREE first issue viewing visit the journal's website at Current Green Chemistry

Chemical Abstracts Service (CAS) aims to deliver comprehensive and useful digital information environment for scientific research and discovery.

Bussum, Netherlands, 21 January 2014: Bentham Science is proud to announce the release of a new journal, Clinical Cancer Drugs in January 2014. This new journal is available in both print and electronic editions. The inaugural journal issue is available online for free viewing via http://www.benthamscience.com/journals/clinical-cancer-drugs/volume/1/issue/1/.

Clinical Cancer Drugs aims to publish expert reviews, original research and thematic issues on all major areas of translational and clinical cancer drug research. For more details please visit the journal's website Clinical Cancer Drugs

Bussum, Netherlands, 14 January 2014: Bentham Science is proud to announce the launch of Current Biochemical Engineering in January 2014. This new journal is available in both print and electronic versions. The introductory journal issue is available online for free via http://www.benthamscience.com/journals/current-biochemical-engineering/volume/1/issue/1/

Current Biochemical Engineering aims to publish the best review articles on all related major advances in biochemical engineering. For Further details about this new journal, you can visit the website at Current Biochemical Engineering

Bussum, Netherlands, 14 January 2014: Bentham Science announce the launch of Current Green Chemistry in January 2014. This journal aims to publish expert reviews and original research in all major areas of Green Chemistry.

For more details about the journal, visit at Current Green Chemistry.

The inaugural journal is available in both electronic and print versions. This issue is available for free online viewing via Current Green Chemistry.

Netherlands, Bussum, December 13: Bentham Science Publishers has completed an agreement with Kobo Inc. to sell its E-books content on the Kobo platform and associated resellers. Some E-books will be available at the Kobo store from December 2014 with more titles scheduled in 2014. This agreement represents a new step forward for Bentham E-books as the publisher is transitioning towards publishing EPUB Books tailored for multiple platforms. Bentham Science Publishers E-books will be sold via Kobo in addition to Amazon KindleTM, Barnes & Noble and other reputable E-book stores.

Bussum, Netherlands, 18 November 2013: Bentham Science Publishers and the Copyright Clearance Center, Inc. (CCC), a not-for-profit organization and leading provider of licensing solutions, have completed a formal agreement over a referral partnership allowing Bentham Science Publishers to protect copyrighted assets from their online content using CCC's RightsLink® service. The RightsLink® service is now available via Bentham Science's website.

RightsLink® is an easy-to-use licensing solution, enabling rightsholders to offer permissions at the point-of-content – hosted on a website, mobile application or third-party aggregator.

Copyright Clearance Center (CCC), the rights licensing experts, is a global rights broker for the world's most sought after materials, including in- and out-of-print books, journals, newspapers, magazines, movies, television shows, images, blogs and ebooks. Founded in 1978 as a not-for-profit organization, CCC provides smart solutions that simplify the licensing of content that lets businesses and academic institutions quickly get permission to use copyright-protected materials, while compensating publishers and content creators for the use of their works. For more information, visit www.copyright.com.

Bentham Science Publishers publishes over 100 print & online scholarly journals and 200 plus open access publications in 2013. It also published more than 300 eBooks till date. Major fields covered by Bentham journals and eBooks include science, technology, medicine, engineering, chemistry, life sciences, social sciences and pharmaceutical science. For a detailed profile, visit www.benthamscience.com/

Bussum, Netherlands, 25 October, 2013: Chemical Abstracts Service, a division of the American Chemical Society accepts the coverage of 40 eBooks published by Bentham Science Publishers. The list of eBooks recently indexed by CAS can be viwed at (www.benthamscience.com/News/chemical%20abstract.xlsx).

Chemical Abstracts Service aims to deliver a complete and effective digital information environment for global scientific research and discovery. It provides pathways to published research in the world's journal and patent literature relevant to chemistry, life sciences and in other relevant scientific disciplines.

Bentham Science published 353 eBooks up to 2013. Bentham eBooks are published in a range of disciplines including science, technology, medicine, and the social sciences. Bentham eBooks are a useful source of information to academics, corporate researchers, graduates and under-graduates. Bentham eBooks are available on order in a user- friendly PDF format and can be downloaded directly from the website.

Bussum, Netherlands, 26 September, 2013: SciVerse Scopus accepts coverage of 260 e-books published by Bentham Science Publishers. The list of Bentham Ebooks recently indexed by Scopus can be viewed at benthamscience.com/News/Scopusebooks.xlsx.

Scopus is the largest abstract and citation database of peer-reviewed literature and quality web sources with smart tools to track, analyze and visualize research. It is designed to help scientists to fulfill their informational needs.

Bentham Science published 353 ebooks in 2013. These books cover a range of areas in science, technology, medicine, social sciences and humanities. Bentham Ebooks are a useful source of information to academics, corporate researchers, graduates and under-graduates worldwide. Bentham Ebooks are available in user friendly PDF format and can be downloaded directly from the website.

Bussum, Netherlands, September 10, 2013: The Open Urology and Nephrology Journal has recently been designated as the "Official Journal of Nephrology, Urology and Transplantation Society of SAARC (South Asian Association for Regional Cooperation)".

The Open Urology & Nephrology Journal, a peer-reviewed journal, is an important and reliable source of current information on developments in the fields of urology and nephrology.

The nephrologists, urologists and transplant surgeons of the SAARC countries formed an association in 1995 for the exchange of scientific information and improving fellowship between medical specialists working on health promotion, health prevention and health care.

Bussum, Netherlands, July 26, 2013: SciVerse Scopus accepts coverage of (The Open Communication Journal) published by Bentham Science Publishers under the banner of “Bentham Open” Scopus (www.scopus.com/home.url) is the largest abstract and citation database of peer-reviewed literature and quality web sources with smart tools to track, analyze and visualize research. It is designed to help scientists to fulfill their informational needs.

Bentham Open is publishing over 240 peer-reviewed open access journals. These free-to-view online journals cover all major disciplines of science, technology, medicine, engineering, mathematics, chemistry, life sciences, pharmaceutical science, earth sciences, social sciences and environmental science. Published exclusively online, the journals are available for FREE viewing via Bentham OPEN's website at www.benthamscience.com/open. Bentham Open aims to provide scientists, researchers, students and decision makers from academia and industry around the world with freely accessible peer-reviewed published articles.

Bussum, Netherlands, 11 July 2013: MEDLINE® accepts coverage of the journal Current Hypertension Reviews.published by Bentham Science Publishers.

Current Hypertension Reviews publishes frontier reviews on all the latest advances on hypertension research and related areas e.g. nephrology, clinical care, and therapy. For details please visit the journal website at Current Hypertension Reviews

MEDLINE®Medical Literature Analysis and Retrieval System Online) is the U.S. National Library of Medicine's® (NLM) premier bibliographic database that covers areas of the life sciences, behavioral sciences, chemical sciences, and bioengineering. MEDLINE also covers aspects of biology, environmental science, marine biology, plant and animal science as well as biophysics and chemistry. MEDLINE is the primary component of PubMed®, part of the Entrez series of databases provided by NLM's National Center for Biotechnology Information (NCBI). Publications covered in MEDLINE are mostly scholarly journals, newspapers, magazines, and newsletters considered useful in the field of life sciences. For further information about Medline visit www.nlm.nih.gov/pubs/factsheets/medline.html.

Bussum, Netherlands, June 27, 2013: Current Stem Cell Research & Therapy has registered its first Impact Factor at 2.963. The Impact Factor ranking has been awarded by Journal Citation Reports^®, which are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data.

Current Stem Cell Research & Therapy publishes high quality frontier reviews, drug clinical trial studies and guest edited issues on all aspects of basic research on stem cells and their uses in clinical therapy.

Bussum, Netherlands, June 27, 2013: According to the recently released Journal Citation Reports® 2012, eleven Bentham Science Journals have improved their impact factor ratings. The journal Current Stem Cell Research & Therapy has registered its first Impact factor at 2.963. These positive results reflect the quality of research published by Bentham Science.

Journal Citation Reports (JCR) are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data.

Bentham Science Publishers publishes over 100 print & online scholarly journals and 200 plus open access publications in 2013. It also published more than 300 eBooks till date. Major fields covered by Bentham journals and eBooks include science, technology, medicine, engineering, chemistry, life sciences, social sciences and pharmaceutical science. For a detailed profile, visit our website www.benthamscience.com/.

Netherlands, Bussum, 18, June, 2013: Bentham Science, a reputable scientific publisher, launches two more open access journals in the HTML format. The Open Neuroimaging Journal http://benthamopen.com/tonij/home/ & The Open Ceramic Science Journal http://benthamopen.com/tocersj/home/ are both now available in full text HTML version in addition to PDF.

The Journals are peer-reviewed, and important and reliable sources of the latest information on the developments in their respective fields.

Bussum, Netherlands, 13 June 2013: Bentham Science announce the launch of Neuroscience and Biomedical Engineering in June 2013. This new journal is available in both print and electronic editions. The inaugural journal issue is available for free online viewing via http://www.benthamscience.com/journals/neuroscience-and-biomedical-engineering/volume/1/issue/1/.

Neuroscience and Biomedical Engineering aims to publish the best interdisciplinary research in neuroscience and biomedical engineering.

It is the official journal of the Institute of Complex Medical Engineering (ICME). For details visit the journal’s website at http://www.benthamscience.com/journals/neuroscience-and-biomedical-engineering/#top

Netherlands, Bussum, 10, June, 2013: Bentham Science, a reputable scientific publisher, launches its first journal in HTML format. The Open Nursing Journal is now available in full text HTML version in addition to PDF. For more information, please visit http://benthamopen.com/tonursj/home/

The Open Nursing Journal, a peer-reviewed journal, is an important and reliable source of current information on developments in the field.

Bussum, Netherlands, 04, March, 2013: SciVerse Scopus accepts coverage of another three journals published by Bentham Science. The journals recently indexed are: MIicroRNA http://www.benthamscience.com/journals/microrna/#top, Current Molecular Imaging http://www.benthamscience.com/journals/current-molecular-imaging/#top and Current Tissue Engineering http://www.benthamscience.com/journals/current-tissue-engineering/#top

MicroRNA publishes letters, full-length research, review articles, drug clinical trial studies and thematic issues on all aspects of microRNA (miRNA) research.

Current Molecular Imaging publishes peer -reviewed expert review articles and special topic issues on all aspects of experimental and clinical research in molecular imaging.

Current Tissue Engineering is an international peer-reviewed journal, which publishes expert reviews, drug clinical trial studies and thematic issues in all areas of tissue engineering research. For more information about the journals, please visit www.benthamscience.com

Scopus is one of the largest abstract and citation database of peer-reviewed literature and quality web sources with smart tools to track analyze and visualize research.

Congratulations! Recent Patents on Regenerative Medicine and The Open Sports Science Journal have been indexed in SCOPUS.

Journal Citation Reports (JCR) are annually published by the Institute of Scientific Information, a division of Thomson Reuters. Its purpose is to offer a systematic means to critically evaluate the world's leading journals, with quantifiable, statistical information based on citation data. Bentham Science publishes over 100 print & online scholarly subscription journals; website at www.benthamscience.com

Bussum, Netherlands, 21 January, 2013: Chemical Abstracts Service (www.cas.com/), a division of the American Chemical Society accepts to cover a new journal Pharmaceutical Nanotechnology (http://www.benthamscience.com/journals/pharmaceutical-nanotechnology/#top) published by Bentham Science Publishers.

Chemical Abstracts Service aims to deliver complete and effective digital information environment for scientific research and discovery. It provides pathways to published research in the world's journal and patent literature relevant to chemistry, life science and other scientific disciplines.

Pharmaceutical Nanotechnology publishes original manuscripts, reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. For details and FREE first issue viewing visit the journal's website at http://www.benthamscience.com/journals/pharmaceutical-nanotechnology/#top

Bussum, Netherlands, 21 January, 2013: SciVerse Scopus accepts coverage of Recent Patents on Regenerative Medicine http://www.benthamscience.com/journals/recent-patents-on-regenerative-medicine/#top published by Bentham Science Publishers.

Scopus (www.scopus.com/home.url) is one of the largest abstract and citation database of peer-reviewed literature and quality web sources with smart tools to track, analyze and visualize research. It is designed to help scientists to fulfill their informational needs.

Recent Patents on Regenerative Medicine publishes review and research articles, and guest edited thematic issues on important recent patents on regenerative medicine e.g. stem cells, gene therapy, tissue engineering, and tissue and organ regeneration. A selection of important and recent patents on regenerative medicine is also included in the journal. For more information please visit http://www.benthamscience.com/journals/recent-patents-on-regenerative-medicine/#top

Bussum, Netherlands, 4 January 2013: Bentham Science announce the launch of http://www.benthamscience.com/journals/pharmaceutical-nanotechnology/#topPharmaceutical Nanotechnology and http://www.benthamscience.com/journals/current-metabolomics/#topCurrent Metabolomics in January 2013. These new journals are available in both print and electronic editions. The inaugural journal issues are available for free online viewing via http://www.benthamscience.com/journals/pharmaceutical-nanotechnology/volume/1/issue/1/ and http://www.benthamscience.com/journals/current-metabolomics/volume/1/issue/1/ respectively.

Pharmaceutical Nanotechnology publishes original manuscripts, reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or iagnostic) application of materials at the nanoscale. For details visit the journal’s website at http://www.benthamscience.com/journals/pharmaceutical-nanotechnology/#top

Current Metabolomics publishes timely reviews, original research articles, thematic issues, and technical notes covering all aspects of the recent advancements and applications of metabolomics technology to systems biology, disease diagnosis, personalized medicine, and drug discovery. For details visit the journal’s website at http://www.benthamscience.com/journals/current-metabolomics/#top